<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Methods of preventing bacterial sepsis and wound complications after liver transplantation - Gurusamy, KS - 2014 | Cochrane Library</title> <meta content="Methods of preventing bacterial sepsis and wound complications after liver transplantation - Gurusamy, KS - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006660.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Methods of preventing bacterial sepsis and wound complications after liver transplantation - Gurusamy, KS - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006660.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006660.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Methods of preventing bacterial sepsis and wound complications after liver transplantation" name="citation_title"/> <meta content="Kurinchi Selvan Gurusamy" name="citation_author"/> <meta content="Royal Free Campus, UCL Medical School" name="citation_author_institution"/> <meta content="k.gurusamy@ucl.ac.uk" name="citation_author_email"/> <meta content="Myura Nagendran" name="citation_author"/> <meta content="Department of Surgery" name="citation_author_institution"/> <meta content="Brian R Davidson" name="citation_author"/> <meta content="Royal Free Campus, UCL Medical School" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD006660.pub3" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/03/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006660.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006660.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006660.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Liver Transplantation; *Prebiotics; Bacterial Infections [*prevention &amp; control]; Decontamination; Dietary Fiber [administration &amp; dosage]; Granulocyte Colony‐Stimulating Factor [therapeutic use]; Lactobacillus; Probiotics [*therapeutic use]; Randomized Controlled Trials as Topic; Sepsis [*prevention &amp; control]; Surgical Wound Infection [*prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006660.pub3&amp;doi=10.1002/14651858.CD006660.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="8ranHhTh";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006660\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006660\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006660\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006660\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fr","pl","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006660.pub3",title:"Methods of preventing bacterial sepsis and wound complications after liver transplantation",firstPublishedDate:"Mar 5, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Hepato‐Biliary Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=8ranHhTh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006660.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006660.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006660.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006660.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006660.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006660.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006660.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006660.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006660.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006660.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1813 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006660.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-sec-0084"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-sec-0059"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-sec-0078"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/appendices#CD006660-sec-0089"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/table_n/CD006660StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/table_n/CD006660StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Methods of preventing bacterial sepsis and wound complications after liver transplantation</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/information#CD006660-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Kurinchi Selvan Gurusamy</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/information#CD006660-cr-0003">Myura Nagendran</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006660.pub3/information#CD006660-cr-0004">Brian R Davidson</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/information/en#CD006660-sec-0093">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 March 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006660.pub3">https://doi.org/10.1002/14651858.CD006660.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006660-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006660-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006660-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006660-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006660-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006660-abs-0001" lang="en"> <section id="CD006660-sec-0001"> <h3 class="title" id="CD006660-sec-0001">Background</h3> <p>Bacterial sepsis and wound complications after liver transplantation increase mortality, morbidity, or hospital stay and are likely to increase overall transplant costs. All liver transplantation patients receive antibiotic prophylaxis. This is an update of our 2008 Cochrane systematic review on the same topic in which we identified seven randomised clinical trials. </p> </section> <section id="CD006660-sec-0002"> <h3 class="title" id="CD006660-sec-0002">Objectives</h3> <p>To assess the benefits and harms of different methods aimed at preventing bacterial sepsis and wound complications in people undergoing liver transplantation. </p> </section> <section id="CD006660-sec-0003"> <h3 class="title" id="CD006660-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and Science Citation Index Expanded to February 2013. </p> </section> <section id="CD006660-sec-0004"> <h3 class="title" id="CD006660-sec-0004">Selection criteria</h3> <p>We included only randomised clinical trials irrespective of language or publication status. We excluded quasi‐randomised and other observational studies for assessment of benefits, but not for harms. </p> </section> <section id="CD006660-sec-0005"> <h3 class="title" id="CD006660-sec-0005">Data collection and analysis</h3> <p>Two review authors collected the data independently. We calculated the risk ratio (RR) or mean difference (MD) with 95% confidence intervals (CI) using fixed‐effect and the random‐effects models based on available‐case analysis. </p> </section> <section id="CD006660-sec-0006"> <h3 class="title" id="CD006660-sec-0006">Main results</h3> <p>We identified only seven trials for inclusion, including 614 participants. Only one trial was of low risk of bias risk. Overall, the quality of evidence was very low. There were five comparisons in the seven trials: selective bowel decontamination versus inactive control; selective bowel decontamination versus prebiotics with probiotics; selective bowel decontamination versus prebiotics; prebiotics with probiotics versus prebiotics; and granulocyte‐colony stimulating factor (G‐CSF) versus control. Four trials compared selective bowel decontamination versus placebo or no treatment. In one trial, participants were randomised to selective bowel decontamination, active lactobacillus with fibres (probiotic with prebiotic), or to inactivated lactobacillus with fibres (prebiotic). In one trial, active lactobacillus with fibres (probiotic with prebiotic) was compared with inactive lactobacillus with fibres (prebiotic). In the remaining trial, different doses of G‐CSF and placebo were compared. There was no trial comparing different antibiotic prophylactic regimens in people undergoing liver transplantation. Most trials included adults undergoing elective liver transplantation. There was no significant difference in proportion of people who died or required retransplantation between the intervention and control groups in any of the five comparison groups. </p> <p><b>Mortality</b> </p> <p>There were no differences between 190 participants (three trials); 5/87 (adjusted proportion: 6.2%) in selective bowel decontamination group versus 7/103 (6.8%) in inactive control group; RR 0.91 (95% CI 0.31 to 2.72); 63 participants (one trial); 0/32 (0%) in selective bowel decontamination group versus 0/31 (0%) in prebiotics with probiotics group; RR ‐ not estimable; 64 participants (one trial); 0/32 (0%) in selective bowel decontamination group versus 0/32 (0%) in prebiotics group; RR ‐ not estimable; 129 participants (two trials); 0/64 (0%) in prebiotics with probiotics group versus 0/65 (0%) in prebiotics group; RR ‐ not estimable; and 194 participants (one trial); 22/124 (17.7%) in G‐CSF group versus 10/70 (14.3%) in placebo group; RR 1.24 (95% 0.62 to 2.47). </p> <p><b>Retransplantation</b> </p> <p>There were no differences between 132 participants (two trials); 4/58 (adjusted proportion: 6.9%) in selective bowel decontamination group versus 6/74 (8.1%) in inactive control group; RR 0.85 (95% CI 0.26 to 2.85); 63 participants (one trial); 1/32 (3.1%) in selective bowel decontamination group versus 0/31 (0%) in prebiotics with probiotics group; RR 2.91 (0.12 to 68.81); 64 participants (one trial); 1/32 (3.1%) in selective bowel decontamination group versus 0/32 (0%) in prebiotics group; RR 3.00 (95% CI 0.13 to 71.00); 129 participants (two trials); 0/64 (0%) in prebiotics with probiotics group versus 1/65 (1.5%) in prebiotics group; RR 0.33 (95% CI 0.01 to 7.9); and 194 participants (one trial); 10/124 (7.1%) in G‐CSF group versus 5/70 (7.1%) in placebo group; RR 1.13 (95% CI 0.4 to 3.17). </p> <p>There was no significant difference in the graft rejections, intensive therapy unit stay, or hospital stay between the intervention and control groups in any of the comparisons. Overall, 193/611 participants (31.6%) developed infective complications. The proportion of people who developed infective complications and the number of infective complication episodes were significantly higher in the selective bowel decontamination group than in the prebiotics with probiotics group (1 study; 63 participants; 15/32 (46.9%) in selective bowel decontamination group versus 4/31 (12.9%) in prebiotics with probiotics group; RR 3.63; 95% CI 1.36 to 9.74 and 23/32 participants (0.72 infective complications per participant) in selective bowel decontamination group versus 4/31 participants (0.13 infective complications per participant) in prebiotics with probiotics group; rate ratio 5.58; 95% CI 1.94 to 16.09). There was no significant difference between the proportion of participants who developed infection and the number of infection episodes between the intervention group and control group in any of the other comparisons. </p> <p>No trials reported quality of life and overall serious adverse events.</p> </section> <section id="CD006660-sec-0007"> <h3 class="title" id="CD006660-sec-0007">Authors' conclusions</h3> <p>Currently, there is no clear evidence for any intervention offering significant benefits in the reduction of bacterial infections and wound complications in liver transplantation. Selective bowel decontamination may even increase the rate of infections compared with prebiotics with probiotics. The confidence intervals were wide and further randomised clinical trials of low risk of bias are necessary. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006660-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006660-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006660-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006660-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006660-abs-0005">Français</a> </li> <li class="section-language"> <a class="" href="full/pl#CD006660-abs-0006">Polski</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006660-abs-0004" lang="en"> <h3>Interventions to prevent bacterial infective complications and wound complications in liver transplantation </h3> <p><b>Background</b> </p> <p>The liver is an important organ of the body and has various functions including generation of energy from food; production of material necessary for congealing, processing, and excretion of drugs and waste products in blood; and filtering out the harmful bacteria that enter the body through the gut. Alcohol abuse and viral infections can cause damage to the liver usually in an insidious manner. Sometimes, the liver damage can be so severe that the liver is unable to carry out the normal functions, which results in liver failure. Liver transplantation is effective in treating liver failure. However, liver transplantation is major surgical procedure and a significant proportion of people develop infective and wound complications because of the medications given to suppress the recipient body mounting a foreign body response to the liver graft (immunosuppressive regimens). Various interventions have been attempted to prevent the bacterial infective complications and wound complications; however, the effectiveness is unknown. We performed a detailed review of the medical literature (to February 2013) to determine the benefits and harms of different interventions to prevent bacterial infective complications and wound complications in liver transplantation. We sought evidence from randomised clinical trials only. When conducted properly, such trials provide the best evidence. Two review authors independently identified the trials and obtained the information from the trials to minimise error. </p> <p><b>Study characteristics</b> </p> <p>We identified seven trials for inclusion including 614 people. Four trials compared selective bowel decontamination (prolonged use of antibiotics to clear bacteria in the gut) versus placebo (inactive intervention) or no treatment. In one trial, people were randomised to selective bowel decontamination, active lactobacillus with fibres (probiotic with prebiotic), or to inactivated lactobacillus with fibres (prebiotic). In one trial, probiotic with prebiotic was compared with prebiotic. In another trial, different doses of granulocyte‐colony stimulating factor (G‐CSF; substance that stimulates the immune response) and placebo were compared. Most trials included adults undergoing elective liver transplantation. There were five comparisons: selective bowel decontamination versus inactive control; selective bowel decontamination versus prebiotics with probiotics; selective bowel decontamination versus prebiotics; prebiotics with probiotics versus prebiotics; and G‐CSF versus control. There was no trial comparing different antibiotics to prevent bacterial infective complications and wound complications in people undergoing liver transplantation. </p> <p><b>Key results</b> </p> <p>There was no significant difference in proportion of people who died or required retransplantation between the intervention and control groups in any of the five comparisons. There was no significant difference in the graft rejections, intensive therapy unit stay, or hospital stay between the intervention and control groups in any of the comparisons. Overall, 193/611 (31.6%) participants developed infective complications. The proportion of people who developed infective complications and the number of infective complication episodes were significantly higher in the selective bowel decontamination group than prebiotics with probiotics group. There was no significant difference between the proportion of people who developed infection and the number of infective complication episodes between groups in any of the other comparisons. Quality of life and serious adverse events in the groups were not reported in any of the trials. There is no clear evidence that any of the interventions may be of benefit. Selective bowel decontamination may even increase the risk of infection compared to prebiotics with probiotics. </p> <p><b>Quality of evidence</b> </p> <p>Most of the trials were at high risk of systematic errors (there was a potential to arrive at wrong conclusions because of the way the trial was conducted) and random errors (there was a potential to arrive at the wrong conclusions because of the play of chance). The overall quality of evidence is very low. </p> <p><b>Future research</b> </p> <p>Further well‐designed randomised clinical trials are necessary in people undergoing liver transplantation. Such trials should include patient‐oriented outcomes such as mortality, graft failure, quality of life, length of hospital stay, and serious adverse events related to the treatment. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006660-sec-0084" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006660-sec-0084"></div> <h3 class="title" id="CD006660-sec-0085">Implications for practice</h3> <section id="CD006660-sec-0085"> <p>Currently, there is no evidence for any intervention offering significant benefits in the reduction of bacterial infections and wound complications in liver transplantation. All trials used antibiotic prophylaxis. In spite of this, infective complications were still prevalent. </p> </section> <h3 class="title" id="CD006660-sec-0086">Implications for research</h3> <section id="CD006660-sec-0086"> <p>Further randomised clinical trials are necessary to assess interventions to prevent bacterial sepsis and wound complications for liver transplantation. Such trials should include patient‐oriented outcomes such as mortality, graft failure, quality of life, length of hospital stay, and serious adverse events related to the treatment. Trials need to be designed according to the SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) guidelines (<a href="./references#CD006660-bbs2-0063" title="ChanAW , TetzlaffJM , AltmanDG , LaupacisA , GøtzschePC , Krleža‐JerićK , et al. SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Annals of Internal Medicine2013;158:200‐7. ">SPIRIT 2013</a>; <a href="./references#CD006660-bbs2-0064" title="ChanA‐W , TetzlaffJM , GøtzschePC , AltmanDG , MannH , BerlinJ , et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (Clinical Research Ed.)2013;346:e7586. ">SPIRIT 2013a</a>), and conducted and reported according to the CONSORT (CONsolidated Standards of Reporting Trials) Statement (<a href="http://www.consort-statement.org" target="_blank">www.consort‐statement.org</a>). </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006660-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006660-sec-0022"></div> <div class="table" id="CD006660-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Intervention compared to control for people undergoing liver transplantation (mortality)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Mortality</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> people undergoing liver transplantation.<br/> <b>Settings:</b> tertiary.<br/> <b>Intervention:</b> intervention.<br/> <b>Comparison:</b> control. </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comparisons</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Intervention</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Selective bowel decontamination versus inactive control</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>68 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>62 per 1000</b> <br/> (21 to 185) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.91</b> <br/> (0.31 to 2.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>190<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Selective bowel decontamination versus prebiotics with probiotics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No mortality in either group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Selective bowel decontamination versus prebiotics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No mortality in either group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prebiotics with probiotics versus prebiotics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No mortality in either group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Granulocyte‐colony stimulating factor (G‐CSF) versus placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>143 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>177 per 1000</b> <br/> (89 to 353) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.24</b> <br/> (0.62 to 2.47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>194<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> The trial(s) was (were) of high risk of bias.<br/> <sup>2</sup> There was moderate heterogeneity as noted by I<sup>2</sup> statistic.<br/> <sup>3</sup> The confidence intervals overlapped 1 and either 0.75 or 1.25 or both. The number of events in the intervention and control groups was fewer than 300. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD006660-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Intervention compared to control for people undergoing liver transplantation (retransplantation)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Retransplantation</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> people undergoing liver transplantation.<br/> <b>Settings:</b> tertiary.<br/> <b>Intervention:</b> intervention.<br/> <b>Comparison:</b> control. </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comparisons</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Intervention</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Selective bowel decontamination versus inactive control</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>81 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>69 per 1000</b> <br/> (21 to 231) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.85</b> <br/> (0.26 to 2.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>132<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Selective bowel decontamination versus prebiotics with probiotics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000*</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>44 per 1000</b> <br/> (2 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.91</b> <br/> (0.12 to 68.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Selective bowel decontamination versus prebiotics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>16 per 1000*</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 1000</b> <br/> (2 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 3.00</b> <br/> (0.13 to 71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Prebiotics with probiotics versus prebiotics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>15 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>5 per 1000</b> <br/> (0 to 122) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 0.33</b> <br/> (0.01 to 7.90) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>129<br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Granulocyte‐colony stimulating factor (G‐CSF) versus placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>71 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>81 per 1000</b> <br/> (29 to 226) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.13</b> <br/> (0.40 to 3.17) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>194<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the control group risk across studies except for the two comparisons indicated which did not have any retransplantation in the control group. The overall proportion of patients who required retransplantation in the comparison was used as the control group risk in these two comparisons. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> The trial(s) was (were) of high risk of bias.<br/> <sup>2</sup> The confidence intervals overlapped 1 and either 0.75 or 1.25 or both. The number of events in the intervention and control groups was fewer than 300. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006660-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006660-sec-0023"></div> <section id="CD006660-sec-0024"> <h3 class="title" id="CD006660-sec-0024">Description of the condition</h3> <p>Around 700 liver transplantations are performed annually in the UK (<a href="./references#CD006660-bbs2-0050" title="NHS UK Transplant ‐ Annual Report 2003‐2004. www.organdonation.nhs.uk/statistics/transplant_activity_report/current_activity_reports/ukt/liver_activity.pdf (accessed 4 March 2014). ">NHS UK transplant</a>). In the USA, the annual incidence of liver transplantation is 21 per one million population (<a href="./references#CD006660-bbs2-0051" title="Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR). OPTN/SRTR 2009 Annual Report. www.ustransplant.org/annual_reports/current/905_li.pdf (accessed 4 March 2014). ">OPTN/SRTR 2009</a>). Liver transplant is performed mainly for end‐stage liver failure arising acutely (e.g., virus, drug overdose) or as a result of chronic liver disease (e.g., cirrhosis due to alcohol consumption, virus), or for tumours (<a href="./references#CD006660-bbs2-0044" title="LimSG , WaiCT , DaCostaM , SutedjaDS , LeeYM , LeeKH , et al. Referral patterns and waiting times for liver transplantation in Singapore. Singapore Medical Journal2006;47(7):599‐603. ">Lim 2006</a>). </p> <p>The model for end‐stage liver disease (MELD) score (based on bilirubin, creatinine, and international normalised ratio (INR)) has been suggested as one of the methods of determining the severity of end‐stage liver failure (<a href="./references#CD006660-bbs2-0040" title="KamathPS , WiesnerRH , MalinchocM , KremersW , TherneauTM , KosbergCL , et al. A model to predict survival in patients with end‐stage liver disease. Hepatology2001;33(2):464‐70. ">Kamath 2001</a>), and is being used as a tool for allocation of donor livers to individual recipients in some countries (<a href="./references#CD006660-bbs2-0062" title="ShiffmanML , SaabS , FengS , AbecassisMI , TzakisAG , GoodrichNP , et al. Liver and intestine transplantation in the United States, 1995‐2004. American Journal of Transplantation2006;6(5 Pt 2):1170‐87. ">Shiffman 2006</a>). A liver graft can be harvested from living donors (<a href="./references#CD006660-bbs2-0018" title="BombuyE , FondevilaC , Rodriguez‐LaizG , FerrerJ , AmadorA , ValentiniM , et al. Ischemic preconditioning in adult living donor liver transplantation, a pilot study [EASL abstract]. Journal of Hepatology2004;40(Suppl 1):39. ">Bombuy 2004</a>), or from deceased donors (<a href="./references#CD006660-bbs2-0043" title="KoneruB , FisherA , HeY , KleinKM , SkurnickJ , WilsonDJ , et al. Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy. Liver Transplantation2005;11(2):196‐202. ">Koneru 2005</a>; <a href="./references#CD006660-bbs2-0023" title="CesconM , GraziGL , GrassiA , RavaioliM , VetroneG , ErcolaniG , et al. Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study. Liver Transplantation2006;12(4):628‐35. ">Cescon 2006</a>). Worldwide, there is a demand for liver transplants in surplus of organ supply. Split liver transplantation (using one deceased donor liver for two recipients, i.e., an adult and a paediatric recipient) has been suggested as a way to decrease the organ shortage for liver transplant (<a href="./references#CD006660-bbs2-0025" title="CornoV , ColledanM , DezzaMC , GuizzettiM , LucianettiA , MaldiniG , et al. Extended right split liver graft for primary transplantation in children and adults. Transplantation International2006;19(6):492‐9. ">Corno 2006</a>). </p> <p>Between 33% and 68% of liver transplant recipients develop bacterial infections (<a href="./references#CD006660-bbs2-0053" title="PatelR , PayaCV . Infections in solid‐organ transplant recipients. Clinical Microbiology Reviews1997;10(1):86‐124. ">Patel 1997</a>). Immune dysfunction in people with cirrhosis may contribute to the increased infections after liver transplantation (<a href="./references#CD006660-bbs2-0019" title="BonnelAR , BunchorntavakulC , ReddyKR . Immune dysfunction and infections in patients with cirrhosis. Clinical Gastroenterology and Hepatology2011;9(9):727‐38. ">Bonnel 2011</a>). Bacterial sepsis and wound complications may result in mortality (<a href="./references#CD006660-bbs2-0032" title="GarbinoJ , RomandJA , PittetD , GiostraE , MenthaG , SuterP . Infection and rejection in liver transplant patients: a 10‐year Swiss single‐centre experience. Swiss Medical Weekly2005;135(39‐40):587‐93. ">Garbino 2005</a>), and are common causes of significant morbidity, prolonged hospitalisation or hospital readmission, reoperation, and are likely to increase overall transplant costs (<a href="./references#CD006660-bbs2-0047" title="MehrabiA , FonouniH , WenteM , SadeghiM , EisenbachC , EnckeJ , et al. Wound complications following kidney and liver transplantation. Clinical Transplantation2006;20(Suppl 17):97‐110. ">Mehrabi 2006</a>). Gastrointestinal infections affect postoperative mortality and morbidity (<a href="./references#CD006660-bbs2-0017" title="BlairJE , KusneS . Bacterial, mycobacterial, and protozoal infections after liver transplantation ‐ part I. Liver Transplantation2005;11(12):1452‐9. ">Blair 2005</a>). </p> </section> <section id="CD006660-sec-0025"> <h3 class="title" id="CD006660-sec-0025">Description of the intervention</h3> <p>Various methods have been attempted to decrease bacterial sepsis and wound complications. These include selective bowel decontamination, which involves reducing the aerobic gram‐negative bacterial and yeast populations of the gastrointestinal tract, without elimination of the anaerobic microbial flora (<a href="./references#CD006660-bbs2-0003" title="HellingerWC , YaoJD , AlvarezS , BlairJE , CawleyJJ , PayaCV , et al. A randomized, prospective, double‐blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation2002;73(12):1904‐9. ">Hellinger 2002</a>; <a href="./references#CD006660-bbs2-0058" title="SafdarN , SaidA , LuceyMR . The role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: a systematic review and meta‐analysis. Liver Transplantation2004;10(7):817‐27. ">Safdar 2004</a>); prebiotics (fibres) (<a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>); probiotics (living lactobacillus) to restore the physiological gastrointestinal flora (<a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>); and different methods of wound closure (<a href="./references#CD006660-bbs2-0030" title="DienerMK , VossS , JensenK , BuchlerMW , SeilerCM . Elective midline laparotomy closure: the INLINE systematic review and meta‐analysis. Annals of Surgery2010;251(5):843‐56. ">Diener 2010</a>). </p> </section> <section id="CD006660-sec-0026"> <h3 class="title" id="CD006660-sec-0026">How the intervention might work</h3> <p>Selective bowel decontamination, prebiotics, and probiotics are aimed at decreasing the harmful bacteria thereby decreasing bacterial translocation (<a href="./references#CD006660-bbs2-0004" title="RayesN , BrammerM , HansenS , MuellerAR , SerkeS , SeehoferD , et al. Early enteral supply of lactobacilli and fiber versus SBD ‐ a prospective randomized trial in liver transplant recipients (abstract). Journal of Hepatology2001;34(1):199. RayesN , SeehoferD , HansenS , BoucseinK , MullerAR , SerkeS , et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation2002;74(1):123‐7. RayesN , SeehoferD , MullerAR , HansenS , BengmarkS , NeuhausP . Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery ‐ results of a prospective trial. Zeitschrift für Gastroenterologie2002;40(10):869‐76. ">Rayes 2002</a>; <a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>). Different methods of wound closure are aimed at decreasing wound complications thereby improving the outcomes of liver transplantation. </p> </section> <section id="CD006660-sec-0027"> <h3 class="title" id="CD006660-sec-0027">Why it is important to do this review</h3> <p>This is an update of a previous Cochrane systematic review assessing the role of the different interventions in preventing bacterial sepsis and wound complications in liver transplantation (<a href="./references#CD006660-bbs2-0072" title="GurusamyKS , KumarY , DavidsonBR . Methods of preventing bacterial sepsis and wound complications for liver transplantation. Cochrane Database of Systematic Reviews2008, Issue 4. [DOI: 10.1002/14651858.CD006660.pub2] ">Gurusamy 2008</a>). Since the role of antiviral and antifungal agents in liver transplantations are considered in different Cochrane reviews (<a href="./references#CD006660-bbs2-0054" title="PlayfordEG , WebsterAC , SorellTC , CraigJC . Antifungal agents for preventing fungal infections in solid organ transplant recipients. Cochrane Database of Systematic Reviews2004, Issue 3. [DOI: 10.1002/14651858.CD004291.pub2] ">Playford 2004</a>; <a href="./references#CD006660-bbs2-0038" title="HodsonEM , BarclayPG , CraigJC , JonesC , KableK , StrippoliGFM , et al. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD003774.pub2] ">Hodson 2005</a>; <a href="./references#CD006660-bbs2-0065" title="StrippoliGF , HodsonEM , JonesCJ , CraigJC . Pre‐emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients. Cochrane Database of Systematic Reviews2006, Issue 1. [DOI: 10.1002/14651858.CD005133.pub2] ">Strippoli 2006</a>), we have excluded these interventions from this review. While sepsis and wound complications are some of the issues in the choice of the immunosuppressive agents after liver transplantation (<a href="./references#CD006660-bbs2-0041" title="KatoT , YoshidaH , SadfarK , MartinezE , NishidaS , MoonJ , et al. Steroid‐free induction and preemptive antiviral therapy for liver transplant recipients with hepatitis C: a preliminary report from a prospective randomized study. Transplant Proceedings2005;37(2):1217‐9. ">Kato 2005</a>), the main outcomes that affect the choice of the immunosuppressive agents are different (<a href="./references#CD006660-bbs2-0035" title="HaddadEM , McAlisterVC , RenoufE , MalthanerR , KjaerMS , GluudLL . Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database of Systematic Reviews2006, Issue 4. [DOI: 10.1002/14651858.CD005161.pub2] ">Haddad 2006</a>), and hence we have excluded the comparisons of immunosuppressive agents with regards to the reduction in sepsis or wound complications from this review. We have also excluded the trials assessing the role of enteral nutrition and surgical interventions (such as method of suturing) in decreasing infections and incisional hernias as these interventions should be considered in separate reviews. By including all the other interventions aimed at preventing bacterial sepsis and wound complications in this review, we aim to provide a comprehensive review of the different methods aimed at preventing these complications in liver transplantation. Since immunosuppression and the transient anhepatic phase during liver transplantation may have a role in the incidence of sepsis and wound complications, we have considered only publications related to liver transplantation. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006660-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006660-sec-0028"></div> <p>To assess the benefits and harms of different methods aimed at preventing bacterial sepsis and wound complications in people undergoing liver transplantation. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006660-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006660-sec-0029"></div> <section id="CD006660-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006660-sec-0031"> <h4 class="title">Types of studies</h4> <p>We considered all randomised clinical trials that compared any intervention aimed at preventing or reducing sepsis and wound complications in liver transplantation (irrespective of language, blinding, publication status, or sample size). We also included randomised trials that compared one intervention aimed at preventing sepsis or wound complications in liver transplantation versus another. </p> <p>We excluded quasi‐randomised trials (i.e., the method of allocating participants to a treatment are not strictly random, e.g., date of birth, hospital record number, alternation) and non‐randomised comparative studies regarding assessment of benefit, but we considered them for inclusion regarding assessment of harms related to the treatment. </p> </section> <section id="CD006660-sec-0032"> <h4 class="title">Types of participants</h4> <p>People who were about to undergo liver transplantation irrespective of age, deceased or living donor, indication for liver transplantation, first transplantation or retransplantation, and the immunosuppressive therapy used. </p> </section> <section id="CD006660-sec-0033"> <h4 class="title">Types of interventions</h4> <p>We included any intervention aimed at preventing sepsis or wound complications (early or late). This includes selective bowel decontamination (using antibiotics), prebiotics, probiotics, as well as other interventions. </p> <p>We excluded the following interventions.</p> <p> <ol id="CD006660-list-0001"> <li> <p>Treatment for established septic or wound complications.</p> </li> <li> <p>The role of different immunosuppressive therapies in reducing sepsis or wound complications.</p> </li> <li> <p>The role of anti‐fungal agents or anti‐viral agents.</p> </li> <li> <p>The role of nutrition.</p> </li> <li> <p>The role of surgical interventions (such as method of suturing).</p> </li> </ol> </p> </section> <section id="CD006660-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD006660-sec-0035"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD006660-list-0002"> <li> <p>Mortality (90‐day mortality and mortality at maximal follow‐up).</p> </li> <li> <p>Retransplantation.</p> </li> <li> <p>Quality of life during and after treatment.</p> </li> <li> <p>Serious adverse events. These were defined as any events that would increase mortality; were life‐threatening; required hospitalisation; resulted in a persistent or significant disability; or any important medical event that might have jeopardised the patient or required intervention to prevent it (<a href="./references#CD006660-bbs2-0039" title="International Conference on Harmonisation Expert Working Group. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR &amp; ICH guidelines. Vol. 1, PA 19063‐2043, USA: Barnett International/PAREXEL, 1997. ">ICH‐GCP 1997</a>). </p> </li> </ol> </p> </section> <section id="CD006660-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD006660-list-0003"> <li> <p>Infective complications (infected abdominal collections, liver and biliary tract infection, chest infection, urinary infection, wound infection, miscellaneous infections, bacteraemia, septicaemia, sepsis syndrome) as defined by authors. </p> </li> <li> <p>Intensive therapy unit stay.</p> </li> <li> <p>Total hospital stay.</p> </li> </ol> </p> </section> </section> </section> <section id="CD006660-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD006660-sec-0038"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (Issue 1, 2013), MEDLINE, EMBASE, and Science Citation Index Expanded (<a href="./references#CD006660-bbs2-0057" title="RoyleP , MilneR . Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care2003;19(4):591‐603. ">Royle 2003</a>) to February 2013. We have given the search strategies with the time spans for the searches in <a href="./appendices#CD006660-sec-0090">Appendix 1</a>. </p> </section> <section id="CD006660-sec-0039"> <h4 class="title">Searching other resources</h4> <p>We also searched the references of the identified trials to identify further relevant trials. </p> </section> </section> <section id="CD006660-sec-0040"> <h3 class="title" id="CD006660-sec-0040">Data collection and analysis</h3> <section id="CD006660-sec-0041"> <h4 class="title">Selection of studies</h4> <p>KG and MN independently identified the trials for inclusion (<a href="./references#CD006660-sec-0100" title="">Characteristics of included studies</a>). We have listed the excluded studies with the reasons for the exclusion (<a href="./references#CD006660-sec-0101" title="">Characteristics of excluded studies</a>). </p> </section> <section id="CD006660-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>KG and MN independently extracted the following data.</p> <p> <ol id="CD006660-list-0004"> <li> <p>Year and language of publication.</p> </li> <li> <p>Country.</p> </li> <li> <p>Year of conduct of trial.</p> </li> <li> <p>Inclusion and exclusion criteria.</p> </li> <li> <p>Adult or paediatric.</p> </li> <li> <p>Population characteristics such as recipient age, sex ratio, interval between transplantation and treatment. </p> </li> <li> <p>Number undergoing retransplantation.</p> </li> <li> <p>Immunosuppressive therapy.</p> </li> <li> <p>Co‐interventions.</p> </li> <li> <p>Duration of follow‐up.</p> </li> <li> <p>Outcomes (mentioned in <a href="#CD006660-sec-0035">Primary outcomes</a>; <a href="#CD006660-sec-0036">Secondary outcomes</a>). </p> </li> <li> <p>Risk of bias (described in <a href="#CD006660-sec-0043">Assessment of risk of bias in included studies</a>). </p> </li> </ol> </p> <p>We sought any unclear or missing information clarified by contacting the authors of the individual trials. If there was any doubt whether the trials shared the same participants ‐ completely or partially (by identifying common authors and centres) ‐ we intended to contact the authors of the trials to clarify whether the trial report had been duplicated. However, we had no such instances. It was clear from the multiple reports that they all reported on the same participants. </p> <p>We resolved any differences in opinion through discussion and in case of unsettled disagreements, BRD adjudicated. </p> </section> <section id="CD006660-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>KG and MN assessed the bias risk of the trials independently, without masking of the trial names. We followed the instructions given in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006660-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>), and the Cochrane Hepato‐Biliary Group Module (<a href="./references#CD006660-bbs2-0034" title="GurusamyKS , GluudC , NikolovaD , DavidsonBR . Assessment of risk of bias in randomized clinical trials in surgery. British Journal of Surgery2009;96(4):342‐9. [PUBMED: 19283747] ">Gurusamy 2009</a>; <a href="./references#CD006660-bbs2-0033" title="GluudC , NikolovaD , KlingenbergSL , AlexakisN , Als‐NielsenB , ColliA , et al. Cochrane Hepato‐Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2013, Issue 5. Art. No.: LIVER. ">Gluud 2013</a>). Due to the risk of biased overestimation of intervention effects in randomised trials with high risk of bias (<a href="./references#CD006660-bbs2-0061" title="SchulzKF , ChalmersI , HayesRJ , AltmanDG . Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA1995;273(5):408‐12. ">Schulz 1995</a>; <a href="./references#CD006660-bbs2-0048" title="MoherD , PhamB , JonesA , CookDJ , JadadAR , MoherM , et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses?. Lancet1998;352(9128):609‐13. ">Moher 1998</a>; <a href="./references#CD006660-bbs2-0042" title="KjaergardLL , VillumsenJ , GluudC . Reported methodologic quality and discrepancies between large and small randomized trials in meta‐analyses. Annals of Internal Medicine2001;135(11):982‐9. ">Kjaergard 2001</a>; <a href="./references#CD006660-bbs2-0071" title="WoodL , EggerM , GluudLL , SchulzKF , JüniP , AltmanGD , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ (Clinical Research Ed.)2008;336:601‐5. ">Wood 2008</a>; <a href="./references#CD006660-bbs2-0045" title="LundhA , SismondoS , LexchinJ , BusuiocOA , BeroL . Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2] ">Lundh 2012</a>; <a href="./references#CD006660-bbs2-0059" title="SavovićJ , JonesHE , AltmanDG , HarrisRJ , JüniP , PildalJ , et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Health Technology Assessment2012;16(35):1‐82. ">Savović 2012</a>; <a href="./references#CD006660-bbs2-0060" title="SavovićJ , JonesHE , AltmanDG , HarrisRJ , JüniP , PildalJ , et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine2012;157(6):429‐38. ">Savović 2012a</a>), we assessed the following domains of risk of bias in the trials. </p> <section id="CD006660-sec-0044"> <h5 class="title">Allocation sequence generation</h5> <p> <ul id="CD006660-list-0005"> <li> <p>Low risk of bias: sequence generation was achieved using computer random number generation or a random number table. Drawing lots, tossing a coin, shuffling cards, and throwing dice were adequate if performed by an independent person not otherwise involved in the trial. </p> </li> <li> <p>Uncertain risk of bias: the method of sequence generation was not specified.</p> </li> <li> <p>High risk of bias: the sequence generation method was not random.</p> </li> </ul> </p> </section> <section id="CD006660-sec-0045"> <h5 class="title">Allocation concealment</h5> <p> <ul id="CD006660-list-0006"> <li> <p>Low risk of bias: the participant allocations could not have been foreseen in advance of, or during, enrolment. Allocation was controlled by a central and independent randomisation unit. The allocation sequence was unknown to the investigators (e.g., if the allocation sequence was hidden in sequentially numbered, opaque, and sealed envelopes). </p> </li> <li> <p>Uncertain risk of bias: the method used to conceal the allocation was not described so that intervention allocations may have been foreseen in advance of, or during, enrolment. </p> </li> <li> <p>High risk of bias: the allocation sequence was likely to be known to the investigators who assigned the participants. </p> </li> </ul> </p> </section> <section id="CD006660-sec-0046"> <h5 class="title">Blinding of participants, personnel, and outcome assessors</h5> <p> <ul id="CD006660-list-0007"> <li> <p>Low risk of bias: blinding was performed adequately, or the assessment of outcomes was not likely to be influenced by lack of blinding. </p> </li> <li> <p>Uncertain risk of bias: there was insufficient information to assess whether blinding was likely to induce bias on the results. </p> </li> <li> <p>High risk of bias: no blinding or incomplete blinding, and the assessment of outcomes were likely to be influenced by lack of blinding. </p> </li> </ul> </p> </section> <section id="CD006660-sec-0047"> <h5 class="title">Incomplete outcome data</h5> <p> <ul id="CD006660-list-0008"> <li> <p>Low risk of bias: missing data were unlikely to make treatment effects depart from plausible values. Sufficient methods, such as multiple imputation, were employed to handle missing data. </p> </li> <li> <p>Uncertain risk of bias: there was insufficient information to assess whether missing data in combination with the method used to handle missing data were likely to induce bias on the results. </p> </li> <li> <p>High risk of bias: the results were likely to be biased due to missing data.</p> </li> </ul> </p> </section> <section id="CD006660-sec-0048"> <h5 class="title">Selective outcome reporting</h5> <p> <ul id="CD006660-list-0009"> <li> <p>Low risk of bias: all outcomes were pre‐defined and reported, or all clinically relevant and reasonably expected outcomes were reported. </p> </li> <li> <p>Uncertain risk of bias: it is unclear whether all pre‐defined and clinically relevant and reasonably expected outcomes were reported. </p> </li> <li> <p>High risk of bias: one or more clinically relevant and reasonably expected outcomes were not reported, and data on these outcomes were likely to have been recorded. </p> </li> </ul> </p> </section> <section id="CD006660-sec-0049"> <h5 class="title">For‐profit bias</h5> <p> <ul id="CD006660-list-0010"> <li> <p>Low risk of bias: the trial appeared to be free of industry sponsorship or other type of for‐profit support that may manipulate the trial design, conductance, or results of the trial. </p> </li> <li> <p>Uncertain risk of bias: the trial may or may not be free of for‐profit bias as no information on clinical trial support or sponsorship was provided. </p> </li> <li> <p>High risk of bias: the trial was sponsored by industry or received other type of for‐profit support. </p> </li> </ul> </p> <p>We classified trials to be with low risk of bias if judged with low risk of bias in all domains. We classified the trials assessed with uncertain risk of bias or high risk of bias in any domain as trials with high risk of bias. </p> </section> </section> <section id="CD006660-sec-0050"> <h4 class="title">Measures of treatment effect</h4> <p>We performed the meta‐analyses according to the recommendations of The Cochrane Collaboration (<a href="./references#CD006660-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>), and the Cochrane Hepato‐Biliary Group Module (<a href="./references#CD006660-bbs2-0033" title="GluudC , NikolovaD , KlingenbergSL , AlexakisN , Als‐NielsenB , ColliA , et al. Cochrane Hepato‐Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2013, Issue 5. Art. No.: LIVER. ">Gluud 2013</a>), using the software package Review Manager 5 (<a href="./references#CD006660-bbs2-0056" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). For dichotomous variables, we calculated the risk ratio (RR) with 95% confidence intervals (CI). For continuous variables, we calculated the mean difference (MD) with 95% CI. For count data outcomes such as infection episodes, we calculated the rate ratio (RaR) with 95% CI using the methods shown in Section 9.4.8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006660-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). Such a calculation needs the time that the participants were exposed to the risk of infection in each of the groups. We considered that both groups were exposed to the risk of infection for the same time period, which is a reasonable assumption considering that the participants were followed up for the same time in both groups. For time‐to‐event outcomes, we planned to calculate the hazard ratio (HR) with 95% CI. </p> </section> <section id="CD006660-sec-0051"> <h4 class="title">Unit of analysis issues</h4> <p>The units of analysis were the people undergoing liver transplantation.</p> </section> <section id="CD006660-sec-0052"> <h4 class="title">Dealing with missing data</h4> <p>We performed the analysis on an intention‐to‐treat basis whenever possible (<a href="./references#CD006660-bbs2-0049" title="NewellDJ . Intention‐to‐treat analysis: implications for quantitative and qualitative research. International Journal of Epidemiology1992;21(5):837‐41. ">Newell 1992</a>). Otherwise, we performed an available‐case analysis (<a href="./references#CD006660-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). In the absence of summary information, such as mean and standard deviation for continuous outcomes, we used the median for the meta‐analysis when the mean was not available and imputed the standard deviation from P values according to the instructions given in the <i>Cochrane Handbook for Systematic Reviews of Intervention</i> (<a href="./references#CD006660-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). If it was not possible to calculate the standard deviation from the P value or the CIs, we imputed the standard deviation as the highest standard deviation in the other trials included under that outcome, fully recognising that this form of imputation would decrease the weight of the study for calculation of MDs and bias the effect estimate to no effect in case of standardised mean difference (<a href="./references#CD006660-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). For time‐to‐event outcomes, we planned to calculate the natural logarithm of the HR and its standard error using methods suggested by Parmar et al. (<a href="./references#CD006660-bbs2-0052" title="ParmarMK , TorriV , StewartL . Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine1998;17(24):2815‐34. [PUBMED: 9921604] ">Parmar 1998</a>). </p> </section> <section id="CD006660-sec-0053"> <h4 class="title">Assessment of heterogeneity</h4> <p>We explored heterogeneity using the Chi<sup>2</sup> test with significance set at P value 0.10, and measured the quantity of heterogeneity using the I<sup>2</sup> statistic (<a href="./references#CD006660-bbs2-0036" title="HigginsJPT , ThompsonSG . Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine2002;21(11):1539‐58. ">Higgins 2002</a>). We also used overlapping of CIs on the forest plot to determine heterogeneity. </p> </section> <section id="CD006660-sec-0054"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to use visual asymmetry on a funnel plot to explore reporting bias if 10 or more trials were identified (<a href="./references#CD006660-bbs2-0031" title="EggerM , DaveySG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.)1997;315(7109):629‐34. ">Egger 1997</a>; <a href="./references#CD006660-bbs2-0046" title="MacaskillP , WalterSD , IrwigL . A comparison of methods to detect publication bias in meta‐analysis. Statistics in Medicine2001;20(4):641‐54. ">Macaskill 2001</a>). We also planned to perform linear regression approach described by <a href="./references#CD006660-bbs2-0031" title="EggerM , DaveySG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.)1997;315(7109):629‐34. ">Egger 1997</a> to determine the funnel plot asymmetry. </p> </section> <section id="CD006660-sec-0055"> <h4 class="title">Data synthesis</h4> <p>We performed the meta‐analyses using the software package Review Manager 5 (<a href="./references#CD006660-bbs2-0056" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>), and following the recommendations of The Cochrane Collaboration (<a href="./references#CD006660-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>), and the Cochrane Hepato‐Biliary Group Module (<a href="./references#CD006660-bbs2-0033" title="GluudC , NikolovaD , KlingenbergSL , AlexakisN , Als‐NielsenB , ColliA , et al. Cochrane Hepato‐Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2013, Issue 5. Art. No.: LIVER. ">Gluud 2013</a>). We used both a random‐effects model (<a href="./references#CD006660-bbs2-0029" title="DerSimonianR , LairdN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7(3):177‐88. ">DerSimonian 1986</a>), and a fixed‐effect model (<a href="./references#CD006660-bbs2-0028" title="DeMetsDL . Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine1987;6(3):341‐50. ">DeMets 1987</a>), meta‐analyses. In case of discrepancy between the two models resulting in change of conclusions, we have reported both results; otherwise, we have reported the results of the fixed‐effect model. </p> <section id="CD006660-sec-0056"> <h5 class="title">Trial sequential analysis</h5> <p>We used trial sequential analysis to control for random errors due to sparse data and repetitive testing of the accumulating data (<a href="./references#CD006660-bbs2-0026" title="Copenhagen Trial Unit. TSA ‐ Trial Sequential Analysis, 2011. ctu.dk/tsa/ (accessed 4 March 2014). ">CTU 2011</a>; <a href="./references#CD006660-bbs2-0068" title="ThorlundK , EngstrømJ , WetterslevJ , BrokJ , ImbergerG , GluudC . User manual for Trial Sequential Analysis (TSA), 2011. ctu.dk/tsa/files/tsa_manual.pdf (accessed 4 March 2014). ">Thorlund 2011</a>). We added the trials according to the year of publication, and, if more than one trial was published in a year, we added the trials in alphabetical order according to the last name of the first author. We constructed the trial sequential monitoring boundaries on the basis of the diversity‐adjusted required information size (DARIS) (<a href="./references#CD006660-bbs2-0021" title="BrokJ , ThorlundK , GluudC , WetterslevJ . Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta‐analyses. Journal of Clinical Epidemiology2008;61:763‐9. ">Brok 2008</a>; <a href="./references#CD006660-bbs2-0069" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61(1):64‐75. ">Wetterslev 2008</a>; <a href="./references#CD006660-bbs2-0022" title="BrokJ , ThorlundK , WetterslevJ , GluudC . Apparently conclusive meta‐analyses may be inconclusive ‐ trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta‐analyses. International Journal of Epidemiology2009;38(1):287‐98. ">Brok 2009</a>; <a href="./references#CD006660-bbs2-0066" title="ThorlundK , DevereauxPJ , WetterslevJ , GuyattG , IoannidisJP , ThabaneL , et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta‐analyses. International Journal of Epidemiology2009;38(1):276‐86. ">Thorlund 2009</a>; <a href="./references#CD006660-bbs2-0070" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology2009;9:86. ">Wetterslev 2009</a>; <a href="./references#CD006660-bbs2-0067" title="ThorlundK , AnemaA , MillsE . Interpreting meta‐analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV‐infected individuals. Clinical Epidemiology2010;2:57‐66. ">Thorlund 2010</a>). </p> <p>We calculated the diversity‐adjusted required sample size calculated from an alpha error of 0.05; a beta error of 0.20; a control group proportion obtained from the results; and a relative risk reduction of 20% for mortality, retransplantation, graft rejection requiring medical treatment, and proportion of participants with infective complications when there were at least two trials to determine whether more trials are necessary on this topic (if the trial sequential monitoring boundary and the required information size was reached or the futility zone was crossed, then more trials were unnecessary) and the observed diversity (<a href="./references#CD006660-bbs2-0021" title="BrokJ , ThorlundK , GluudC , WetterslevJ . Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta‐analyses. Journal of Clinical Epidemiology2008;61:763‐9. ">Brok 2008</a>; <a href="./references#CD006660-bbs2-0069" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology2008;61(1):64‐75. ">Wetterslev 2008</a>; <a href="./references#CD006660-bbs2-0022" title="BrokJ , ThorlundK , WetterslevJ , GluudC . Apparently conclusive meta‐analyses may be inconclusive ‐ trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta‐analyses. International Journal of Epidemiology2009;38(1):287‐98. ">Brok 2009</a>; <a href="./references#CD006660-bbs2-0066" title="ThorlundK , DevereauxPJ , WetterslevJ , GuyattG , IoannidisJP , ThabaneL , et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta‐analyses. International Journal of Epidemiology2009;38(1):276‐86. ">Thorlund 2009;</a><a href="./references#CD006660-bbs2-0070" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology2009;9:86. ">Wetterslev 2009</a>; <a href="./references#CD006660-bbs2-0067" title="ThorlundK , AnemaA , MillsE . Interpreting meta‐analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV‐infected individuals. Clinical Epidemiology2010;2:57‐66. ">Thorlund 2010</a>). For intensive therapy unit stay and length of hospital stay, we planned to calculate the required sample size from an alpha error of 0.05, a beta error of 0.20, the variance estimated from the meta‐analysis results of low risk of bias trials (if possible), and a minimal clinically relevant difference of one day. We did not plan to perform trial sequential analysis for quality of life and number of infectious episodes as it is not possible to perform trial sequential analysis for standardised mean difference or RaRs. </p> </section> </section> <section id="CD006660-sec-0057"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to perform the following subgroup analysis. </p> <p> <ul id="CD006660-list-0011"> <li> <p>Trials with low bias risk compared to trials with high bias risk. </p> </li> <li> <p>Adult compared to paediatric liver transplantation. </p> </li> <li> <p>Trials with additional antibiotic prophylaxis compared to trials without additional antibiotic prophylaxis.  </p> </li> <li> <p>Trials with immunosuppressive regimen compared to trials without steroid in the immunosuppressive regimen.  </p> </li> <li> <p>Trials with different immunosuppressive regimens compared to each other.</p> </li> </ul> </p> </section> <section id="CD006660-sec-0058"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform a sensitivity analysis excluding the trials in which mean or standard deviation, or both, were imputed from the analysis. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006660-sec-0059" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006660-sec-0059"></div> <section id="CD006660-sec-0060"> <h3 class="title">Description of studies</h3> <p>We identified 10,594 references through electronic searches of CENTRAL (485 references), MEDLINE (5520 references), EMBASE (3210 references), and Science Citation Index Expanded (1379 references). We excluded 2268 duplicates and 8306 clearly irrelevant references through reading abstracts. We retrieved 20 references for further assessment. We did not identify any references through scanning reference lists of the identified randomised trials. We excluded eight references for the reasons listed in the <a href="./references#CD006660-sec-0101" title="">Characteristics of excluded studies</a> table. Twelve references of seven randomised trials involving 614 participants fulfilled the inclusion criteria and provided data for this systematic review (<a href="./references#CD006660-bbs2-0002" title="BadgerIL , CrosbyHA , KongKL , BakerJP , HutchingsP , ElliottTS , et al. Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplantation Proceedings1991;23(1 Part 2):1460‐1. BionJF , BadgerI , CrosbyHA , HutchingsP , KongKL , BakerJ , et al. Selective decontamination of the digestive tract reduces gram‐negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Critical Care Medicine1994;22(1):40‐9. ">Bion 1994</a>; <a href="./references#CD006660-bbs2-0001" title="ArnowPM , CarandangGC , ZabnerR , IrwinME . Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clinical Infectious Diseases1996;22(6):997‐1003. ">Arnow 1996</a>; <a href="./references#CD006660-bbs2-0006" title="WinstonDJ , FosterPF , SombergKA , BusuttilRW , LevyMF , SheinerPA , et al. Randomized, placebo‐controlled, double‐blind, multicenter trial of efficacy and safety of granulocyte colony‐stimulating factor in liver transplant recipients. Transplantation1999;68(9):1298‐304. ">Winston 1999</a>; <a href="./references#CD006660-bbs2-0003" title="HellingerWC , YaoJD , AlvarezS , BlairJE , CawleyJJ , PayaCV , et al. A randomized, prospective, double‐blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation2002;73(12):1904‐9. ">Hellinger 2002</a>; <a href="./references#CD006660-bbs2-0004" title="RayesN , BrammerM , HansenS , MuellerAR , SerkeS , SeehoferD , et al. Early enteral supply of lactobacilli and fiber versus SBD ‐ a prospective randomized trial in liver transplant recipients (abstract). Journal of Hepatology2001;34(1):199. RayesN , SeehoferD , HansenS , BoucseinK , MullerAR , SerkeS , et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation2002;74(1):123‐7. RayesN , SeehoferD , MullerAR , HansenS , BengmarkS , NeuhausP . Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery ‐ results of a prospective trial. Zeitschrift für Gastroenterologie2002;40(10):869‐76. ">Rayes 2002</a>; <a href="./references#CD006660-bbs2-0007" title="MaringJK , ZwavelingJH , KlompmakerIJ , van derMeerJ , SlooffMJ . Selective bowel decontamination in elective liver transplantation: no improvement in endotoxaemia, initial graft function and post‐operative morbidity. Transplant International2002;15(7):329‐34. ZwavelingJH , MaringJK , KlompmakerIJ , HaagsmaEB , BottemaJT , LaseurM , et al. Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo‐controlled trial in liver transplant patients. Critical Care Medicine2002;30(6):1204‐9. vanEnckevortPJ , ZwavelingJH , BottemaJT , MaringJK , KlompmakerIJ , SlooffMJH , et al. Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients. Pharmacoeconomics2001;19(5):523‐30. ">Zwaveling 2002</a>; <a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>). The reference flow is shown in <a href="#CD006660-fig-0001">Figure 1</a>. All the trials used steroids as a part of immunosuppressive therapy. Details about the trial design; sample size; patient characteristics; the inclusion and exclusion criteria used in the trials; intervention and control; the time at which the intervention was commenced and completed; outcomes measured in individual trials; and the risk of bias in the trials are shown in the <a href="./references#CD006660-sec-0100" title="">Characteristics of included studies</a> table. </p> <div class="figure" id="CD006660-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD006660-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>Five trials had two comparison groups and two trials had three comparison groups. Four trials compared selective bowel decontamination versus inactive control (placebo in two trials (<a href="./references#CD006660-bbs2-0003" title="HellingerWC , YaoJD , AlvarezS , BlairJE , CawleyJJ , PayaCV , et al. A randomized, prospective, double‐blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation2002;73(12):1904‐9. ">Hellinger 2002</a>; <a href="./references#CD006660-bbs2-0007" title="MaringJK , ZwavelingJH , KlompmakerIJ , van derMeerJ , SlooffMJ . Selective bowel decontamination in elective liver transplantation: no improvement in endotoxaemia, initial graft function and post‐operative morbidity. Transplant International2002;15(7):329‐34. ZwavelingJH , MaringJK , KlompmakerIJ , HaagsmaEB , BottemaJT , LaseurM , et al. Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo‐controlled trial in liver transplant patients. Critical Care Medicine2002;30(6):1204‐9. vanEnckevortPJ , ZwavelingJH , BottemaJT , MaringJK , KlompmakerIJ , SlooffMJH , et al. Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients. Pharmacoeconomics2001;19(5):523‐30. ">Zwaveling 2002</a>) and no intervention in two trials (<a href="./references#CD006660-bbs2-0002" title="BadgerIL , CrosbyHA , KongKL , BakerJP , HutchingsP , ElliottTS , et al. Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplantation Proceedings1991;23(1 Part 2):1460‐1. BionJF , BadgerI , CrosbyHA , HutchingsP , KongKL , BakerJ , et al. Selective decontamination of the digestive tract reduces gram‐negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Critical Care Medicine1994;22(1):40‐9. ">Bion 1994</a>; <a href="./references#CD006660-bbs2-0001" title="ArnowPM , CarandangGC , ZabnerR , IrwinME . Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clinical Infectious Diseases1996;22(6):997‐1003. ">Arnow 1996</a>)). One trial compared selective bowel decontamination, active lactobacillus with fibres (probiotic with prebiotic), and inactivated lactobacillus with fibres (prebiotic) (<a href="./references#CD006660-bbs2-0004" title="RayesN , BrammerM , HansenS , MuellerAR , SerkeS , SeehoferD , et al. Early enteral supply of lactobacilli and fiber versus SBD ‐ a prospective randomized trial in liver transplant recipients (abstract). Journal of Hepatology2001;34(1):199. RayesN , SeehoferD , HansenS , BoucseinK , MullerAR , SerkeS , et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation2002;74(1):123‐7. RayesN , SeehoferD , MullerAR , HansenS , BengmarkS , NeuhausP . Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery ‐ results of a prospective trial. Zeitschrift für Gastroenterologie2002;40(10):869‐76. ">Rayes 2002</a>). One trial compared prebiotic with probiotic versus prebiotic (<a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>). One trial compared different doses of granulocyte‐colony stimulating factor (G‐CSF) versus placebo (<a href="./references#CD006660-bbs2-0006" title="WinstonDJ , FosterPF , SombergKA , BusuttilRW , LevyMF , SheinerPA , et al. Randomized, placebo‐controlled, double‐blind, multicenter trial of efficacy and safety of granulocyte colony‐stimulating factor in liver transplant recipients. Transplantation1999;68(9):1298‐304. ">Winston 1999</a>). </p> <p>We found no trials assessing the benefits and harms of different antibiotic prophylactic regimens or wound closure techniques in the incidence of wound complications after liver transplantation. </p> <section id="CD006660-sec-0061"> <h4 class="title">Selective bowel decontamination versus inactive control</h4> <p>A total of 259 participants who underwent liver transplantation were randomised in four trials to selective bowel decontamination (n = 123) versus control (placebo, antifungal preparation, or no intervention) (n = 136) (<a href="./references#CD006660-bbs2-0002" title="BadgerIL , CrosbyHA , KongKL , BakerJP , HutchingsP , ElliottTS , et al. Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplantation Proceedings1991;23(1 Part 2):1460‐1. BionJF , BadgerI , CrosbyHA , HutchingsP , KongKL , BakerJ , et al. Selective decontamination of the digestive tract reduces gram‐negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Critical Care Medicine1994;22(1):40‐9. ">Bion 1994</a>; <a href="./references#CD006660-bbs2-0001" title="ArnowPM , CarandangGC , ZabnerR , IrwinME . Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clinical Infectious Diseases1996;22(6):997‐1003. ">Arnow 1996</a>; <a href="./references#CD006660-bbs2-0003" title="HellingerWC , YaoJD , AlvarezS , BlairJE , CawleyJJ , PayaCV , et al. A randomized, prospective, double‐blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation2002;73(12):1904‐9. ">Hellinger 2002</a>; <a href="./references#CD006660-bbs2-0007" title="MaringJK , ZwavelingJH , KlompmakerIJ , van derMeerJ , SlooffMJ . Selective bowel decontamination in elective liver transplantation: no improvement in endotoxaemia, initial graft function and post‐operative morbidity. Transplant International2002;15(7):329‐34. ZwavelingJH , MaringJK , KlompmakerIJ , HaagsmaEB , BottemaJT , LaseurM , et al. Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo‐controlled trial in liver transplant patients. Critical Care Medicine2002;30(6):1204‐9. vanEnckevortPJ , ZwavelingJH , BottemaJT , MaringJK , KlompmakerIJ , SlooffMJH , et al. Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients. Pharmacoeconomics2001;19(5):523‐30. ">Zwaveling 2002</a>). The number of participants in each trial ranged from 52 to 80. The proportion of females varied between 35.0% and 80.8%. We were unable to obtain the mean age of participants in one trial (<a href="./references#CD006660-bbs2-0001" title="ArnowPM , CarandangGC , ZabnerR , IrwinME . Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clinical Infectious Diseases1996;22(6):997‐1003. ">Arnow 1996</a>). The mean age of participants in the remaining trials was between 43 and 53 years (<a href="./references#CD006660-bbs2-0002" title="BadgerIL , CrosbyHA , KongKL , BakerJP , HutchingsP , ElliottTS , et al. Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplantation Proceedings1991;23(1 Part 2):1460‐1. BionJF , BadgerI , CrosbyHA , HutchingsP , KongKL , BakerJ , et al. Selective decontamination of the digestive tract reduces gram‐negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Critical Care Medicine1994;22(1):40‐9. ">Bion 1994</a>; <a href="./references#CD006660-bbs2-0003" title="HellingerWC , YaoJD , AlvarezS , BlairJE , CawleyJJ , PayaCV , et al. A randomized, prospective, double‐blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation2002;73(12):1904‐9. ">Hellinger 2002</a>; <a href="./references#CD006660-bbs2-0007" title="MaringJK , ZwavelingJH , KlompmakerIJ , van derMeerJ , SlooffMJ . Selective bowel decontamination in elective liver transplantation: no improvement in endotoxaemia, initial graft function and post‐operative morbidity. Transplant International2002;15(7):329‐34. ZwavelingJH , MaringJK , KlompmakerIJ , HaagsmaEB , BottemaJT , LaseurM , et al. Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo‐controlled trial in liver transplant patients. Critical Care Medicine2002;30(6):1204‐9. vanEnckevortPJ , ZwavelingJH , BottemaJT , MaringJK , KlompmakerIJ , SlooffMJH , et al. Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients. Pharmacoeconomics2001;19(5):523‐30. ">Zwaveling 2002</a>). Three trials included only adults (<a href="./references#CD006660-bbs2-0002" title="BadgerIL , CrosbyHA , KongKL , BakerJP , HutchingsP , ElliottTS , et al. Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplantation Proceedings1991;23(1 Part 2):1460‐1. BionJF , BadgerI , CrosbyHA , HutchingsP , KongKL , BakerJ , et al. Selective decontamination of the digestive tract reduces gram‐negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Critical Care Medicine1994;22(1):40‐9. ">Bion 1994</a>; <a href="./references#CD006660-bbs2-0003" title="HellingerWC , YaoJD , AlvarezS , BlairJE , CawleyJJ , PayaCV , et al. A randomized, prospective, double‐blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation2002;73(12):1904‐9. ">Hellinger 2002</a>; <a href="./references#CD006660-bbs2-0007" title="MaringJK , ZwavelingJH , KlompmakerIJ , van derMeerJ , SlooffMJ . Selective bowel decontamination in elective liver transplantation: no improvement in endotoxaemia, initial graft function and post‐operative morbidity. Transplant International2002;15(7):329‐34. ZwavelingJH , MaringJK , KlompmakerIJ , HaagsmaEB , BottemaJT , LaseurM , et al. Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo‐controlled trial in liver transplant patients. Critical Care Medicine2002;30(6):1204‐9. vanEnckevortPJ , ZwavelingJH , BottemaJT , MaringJK , KlompmakerIJ , SlooffMJH , et al. Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients. Pharmacoeconomics2001;19(5):523‐30. ">Zwaveling 2002</a>). The fourth trial included adults and children (<a href="./references#CD006660-bbs2-0001" title="ArnowPM , CarandangGC , ZabnerR , IrwinME . Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clinical Infectious Diseases1996;22(6):997‐1003. ">Arnow 1996</a>). The time at which intervention was started varied from the time of randomisation to after transplantation was performed. </p> </section> <section id="CD006660-sec-0062"> <h4 class="title">Selective bowel decontamination versus prebiotics with probiotics</h4> <p>A total of 95 participants were randomised in one trial to selective bowel decontamination (n = 32); prebiotics with probiotics (n = 31); and prebiotics (n = 32) (<a href="./references#CD006660-bbs2-0004" title="RayesN , BrammerM , HansenS , MuellerAR , SerkeS , SeehoferD , et al. Early enteral supply of lactobacilli and fiber versus SBD ‐ a prospective randomized trial in liver transplant recipients (abstract). Journal of Hepatology2001;34(1):199. RayesN , SeehoferD , HansenS , BoucseinK , MullerAR , SerkeS , et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation2002;74(1):123‐7. RayesN , SeehoferD , MullerAR , HansenS , BengmarkS , NeuhausP . Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery ‐ results of a prospective trial. Zeitschrift für Gastroenterologie2002;40(10):869‐76. ">Rayes 2002</a>). The proportion of females was 48.9% and the mean age was 49 years (<a href="./references#CD006660-bbs2-0004" title="RayesN , BrammerM , HansenS , MuellerAR , SerkeS , SeehoferD , et al. Early enteral supply of lactobacilli and fiber versus SBD ‐ a prospective randomized trial in liver transplant recipients (abstract). Journal of Hepatology2001;34(1):199. RayesN , SeehoferD , HansenS , BoucseinK , MullerAR , SerkeS , et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation2002;74(1):123‐7. RayesN , SeehoferD , MullerAR , HansenS , BengmarkS , NeuhausP . Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery ‐ results of a prospective trial. Zeitschrift für Gastroenterologie2002;40(10):869‐76. ">Rayes 2002</a>). </p> </section> <section id="CD006660-sec-0063"> <h4 class="title">Prebiotics with probiotics versus prebiotics</h4> <p>A total of 66 participants were randomised in one trial to prebiotics with probiotics (n = 33) and prebiotics (n = 33) (<a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>). The proportion of females was 48.5% and the mean age was 52 years (<a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>). The characteristics of participants eligible for this comparison in another trial (31 participants to prebiotics with probiotics versus 32 participants to prebiotics) have been described under selective bowel decontamination versus prebiotics with probiotics (<a href="./references#CD006660-bbs2-0004" title="RayesN , BrammerM , HansenS , MuellerAR , SerkeS , SeehoferD , et al. Early enteral supply of lactobacilli and fiber versus SBD ‐ a prospective randomized trial in liver transplant recipients (abstract). Journal of Hepatology2001;34(1):199. RayesN , SeehoferD , HansenS , BoucseinK , MullerAR , SerkeS , et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation2002;74(1):123‐7. RayesN , SeehoferD , MullerAR , HansenS , BengmarkS , NeuhausP . Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery ‐ results of a prospective trial. Zeitschrift für Gastroenterologie2002;40(10):869‐76. ">Rayes 2002</a>). </p> </section> <section id="CD006660-sec-0064"> <h4 class="title">Granulocyte‐colony stimulating factor versus placebo</h4> <p>A total of 194 participants were randomised in one trial to G‐CSF (300 micrograms, subcutaneously) (n = 61), G‐CSF (100 micrograms, subcutaneously) (n = 63), and placebo (subcutaneously) (n = 70) (<a href="./references#CD006660-bbs2-0006" title="WinstonDJ , FosterPF , SombergKA , BusuttilRW , LevyMF , SheinerPA , et al. Randomized, placebo‐controlled, double‐blind, multicenter trial of efficacy and safety of granulocyte colony‐stimulating factor in liver transplant recipients. Transplantation1999;68(9):1298‐304. ">Winston 1999</a>). The proportion of females was 42.8% and the mean age was 50 years. </p> </section> </section> <section id="CD006660-sec-0065"> <h3 class="title">Risk of bias in included studies</h3> <p>The risk of bias in the trials is summarised in <a href="#CD006660-fig-0002">Figure 2</a> and <a href="#CD006660-fig-0003">Figure 3</a>. Six trials had low risk of bias due to generation of allocation sequence (<a href="./references#CD006660-bbs2-0002" title="BadgerIL , CrosbyHA , KongKL , BakerJP , HutchingsP , ElliottTS , et al. Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplantation Proceedings1991;23(1 Part 2):1460‐1. BionJF , BadgerI , CrosbyHA , HutchingsP , KongKL , BakerJ , et al. Selective decontamination of the digestive tract reduces gram‐negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Critical Care Medicine1994;22(1):40‐9. ">Bion 1994</a>; <a href="./references#CD006660-bbs2-0001" title="ArnowPM , CarandangGC , ZabnerR , IrwinME . Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clinical Infectious Diseases1996;22(6):997‐1003. ">Arnow 1996</a>; <a href="./references#CD006660-bbs2-0003" title="HellingerWC , YaoJD , AlvarezS , BlairJE , CawleyJJ , PayaCV , et al. A randomized, prospective, double‐blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation2002;73(12):1904‐9. ">Hellinger 2002</a>; <a href="./references#CD006660-bbs2-0004" title="RayesN , BrammerM , HansenS , MuellerAR , SerkeS , SeehoferD , et al. Early enteral supply of lactobacilli and fiber versus SBD ‐ a prospective randomized trial in liver transplant recipients (abstract). Journal of Hepatology2001;34(1):199. RayesN , SeehoferD , HansenS , BoucseinK , MullerAR , SerkeS , et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation2002;74(1):123‐7. RayesN , SeehoferD , MullerAR , HansenS , BengmarkS , NeuhausP . Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery ‐ results of a prospective trial. Zeitschrift für Gastroenterologie2002;40(10):869‐76. ">Rayes 2002</a>; <a href="./references#CD006660-bbs2-0007" title="MaringJK , ZwavelingJH , KlompmakerIJ , van derMeerJ , SlooffMJ . Selective bowel decontamination in elective liver transplantation: no improvement in endotoxaemia, initial graft function and post‐operative morbidity. Transplant International2002;15(7):329‐34. ZwavelingJH , MaringJK , KlompmakerIJ , HaagsmaEB , BottemaJT , LaseurM , et al. Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo‐controlled trial in liver transplant patients. Critical Care Medicine2002;30(6):1204‐9. vanEnckevortPJ , ZwavelingJH , BottemaJT , MaringJK , KlompmakerIJ , SlooffMJH , et al. Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients. Pharmacoeconomics2001;19(5):523‐30. ">Zwaveling 2002</a>; <a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>). Five trials had low risk of bias due to allocation concealment (<a href="./references#CD006660-bbs2-0001" title="ArnowPM , CarandangGC , ZabnerR , IrwinME . Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clinical Infectious Diseases1996;22(6):997‐1003. ">Arnow 1996</a>; <a href="./references#CD006660-bbs2-0003" title="HellingerWC , YaoJD , AlvarezS , BlairJE , CawleyJJ , PayaCV , et al. A randomized, prospective, double‐blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation2002;73(12):1904‐9. ">Hellinger 2002</a>; <a href="./references#CD006660-bbs2-0004" title="RayesN , BrammerM , HansenS , MuellerAR , SerkeS , SeehoferD , et al. Early enteral supply of lactobacilli and fiber versus SBD ‐ a prospective randomized trial in liver transplant recipients (abstract). Journal of Hepatology2001;34(1):199. RayesN , SeehoferD , HansenS , BoucseinK , MullerAR , SerkeS , et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation2002;74(1):123‐7. RayesN , SeehoferD , MullerAR , HansenS , BengmarkS , NeuhausP . Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery ‐ results of a prospective trial. Zeitschrift für Gastroenterologie2002;40(10):869‐76. ">Rayes 2002</a>; <a href="./references#CD006660-bbs2-0007" title="MaringJK , ZwavelingJH , KlompmakerIJ , van derMeerJ , SlooffMJ . Selective bowel decontamination in elective liver transplantation: no improvement in endotoxaemia, initial graft function and post‐operative morbidity. Transplant International2002;15(7):329‐34. ZwavelingJH , MaringJK , KlompmakerIJ , HaagsmaEB , BottemaJT , LaseurM , et al. Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo‐controlled trial in liver transplant patients. Critical Care Medicine2002;30(6):1204‐9. vanEnckevortPJ , ZwavelingJH , BottemaJT , MaringJK , KlompmakerIJ , SlooffMJH , et al. Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients. Pharmacoeconomics2001;19(5):523‐30. ">Zwaveling 2002</a>; <a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>). Four trials had low risk of bias due to blinding of participants, healthcare providers, and outcome assessors (<a href="./references#CD006660-bbs2-0006" title="WinstonDJ , FosterPF , SombergKA , BusuttilRW , LevyMF , SheinerPA , et al. Randomized, placebo‐controlled, double‐blind, multicenter trial of efficacy and safety of granulocyte colony‐stimulating factor in liver transplant recipients. Transplantation1999;68(9):1298‐304. ">Winston 1999</a>; <a href="./references#CD006660-bbs2-0003" title="HellingerWC , YaoJD , AlvarezS , BlairJE , CawleyJJ , PayaCV , et al. A randomized, prospective, double‐blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation2002;73(12):1904‐9. ">Hellinger 2002</a>; <a href="./references#CD006660-bbs2-0007" title="MaringJK , ZwavelingJH , KlompmakerIJ , van derMeerJ , SlooffMJ . Selective bowel decontamination in elective liver transplantation: no improvement in endotoxaemia, initial graft function and post‐operative morbidity. Transplant International2002;15(7):329‐34. ZwavelingJH , MaringJK , KlompmakerIJ , HaagsmaEB , BottemaJT , LaseurM , et al. Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo‐controlled trial in liver transplant patients. Critical Care Medicine2002;30(6):1204‐9. vanEnckevortPJ , ZwavelingJH , BottemaJT , MaringJK , KlompmakerIJ , SlooffMJH , et al. Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients. Pharmacoeconomics2001;19(5):523‐30. ">Zwaveling 2002</a>; <a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>). Only one trial was free from bias due to incomplete outcome data (<a href="./references#CD006660-bbs2-0003" title="HellingerWC , YaoJD , AlvarezS , BlairJE , CawleyJJ , PayaCV , et al. A randomized, prospective, double‐blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation2002;73(12):1904‐9. ">Hellinger 2002</a>). There were post‐randomisation drop‐outs in the remaining trials and these trials are considered to be at high risk of bias due to incomplete outcome data (<a href="./references#CD006660-bbs2-0002" title="BadgerIL , CrosbyHA , KongKL , BakerJP , HutchingsP , ElliottTS , et al. Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplantation Proceedings1991;23(1 Part 2):1460‐1. BionJF , BadgerI , CrosbyHA , HutchingsP , KongKL , BakerJ , et al. Selective decontamination of the digestive tract reduces gram‐negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Critical Care Medicine1994;22(1):40‐9. ">Bion 1994</a>; <a href="./references#CD006660-bbs2-0001" title="ArnowPM , CarandangGC , ZabnerR , IrwinME . Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clinical Infectious Diseases1996;22(6):997‐1003. ">Arnow 1996</a>; <a href="./references#CD006660-bbs2-0006" title="WinstonDJ , FosterPF , SombergKA , BusuttilRW , LevyMF , SheinerPA , et al. Randomized, placebo‐controlled, double‐blind, multicenter trial of efficacy and safety of granulocyte colony‐stimulating factor in liver transplant recipients. Transplantation1999;68(9):1298‐304. ">Winston 1999</a>; <a href="./references#CD006660-bbs2-0007" title="MaringJK , ZwavelingJH , KlompmakerIJ , van derMeerJ , SlooffMJ . Selective bowel decontamination in elective liver transplantation: no improvement in endotoxaemia, initial graft function and post‐operative morbidity. Transplant International2002;15(7):329‐34. ZwavelingJH , MaringJK , KlompmakerIJ , HaagsmaEB , BottemaJT , LaseurM , et al. Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo‐controlled trial in liver transplant patients. Critical Care Medicine2002;30(6):1204‐9. vanEnckevortPJ , ZwavelingJH , BottemaJT , MaringJK , KlompmakerIJ , SlooffMJH , et al. Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients. Pharmacoeconomics2001;19(5):523‐30. ">Zwaveling 2002</a>; <a href="./references#CD006660-bbs2-0004" title="RayesN , BrammerM , HansenS , MuellerAR , SerkeS , SeehoferD , et al. Early enteral supply of lactobacilli and fiber versus SBD ‐ a prospective randomized trial in liver transplant recipients (abstract). Journal of Hepatology2001;34(1):199. RayesN , SeehoferD , HansenS , BoucseinK , MullerAR , SerkeS , et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation2002;74(1):123‐7. RayesN , SeehoferD , MullerAR , HansenS , BengmarkS , NeuhausP . Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery ‐ results of a prospective trial. Zeitschrift für Gastroenterologie2002;40(10):869‐76. ">Rayes 2002</a>; <a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>). Five trials reported mortality and retransplantation and were considered to be at low risk of bias due to selective outcome reporting (<a href="./references#CD006660-bbs2-0002" title="BadgerIL , CrosbyHA , KongKL , BakerJP , HutchingsP , ElliottTS , et al. Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplantation Proceedings1991;23(1 Part 2):1460‐1. BionJF , BadgerI , CrosbyHA , HutchingsP , KongKL , BakerJ , et al. Selective decontamination of the digestive tract reduces gram‐negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Critical Care Medicine1994;22(1):40‐9. ">Bion 1994</a>; <a href="./references#CD006660-bbs2-0006" title="WinstonDJ , FosterPF , SombergKA , BusuttilRW , LevyMF , SheinerPA , et al. Randomized, placebo‐controlled, double‐blind, multicenter trial of efficacy and safety of granulocyte colony‐stimulating factor in liver transplant recipients. Transplantation1999;68(9):1298‐304. ">Winston 1999</a>; <a href="./references#CD006660-bbs2-0003" title="HellingerWC , YaoJD , AlvarezS , BlairJE , CawleyJJ , PayaCV , et al. A randomized, prospective, double‐blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation2002;73(12):1904‐9. ">Hellinger 2002</a>; <a href="./references#CD006660-bbs2-0004" title="RayesN , BrammerM , HansenS , MuellerAR , SerkeS , SeehoferD , et al. Early enteral supply of lactobacilli and fiber versus SBD ‐ a prospective randomized trial in liver transplant recipients (abstract). Journal of Hepatology2001;34(1):199. RayesN , SeehoferD , HansenS , BoucseinK , MullerAR , SerkeS , et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation2002;74(1):123‐7. RayesN , SeehoferD , MullerAR , HansenS , BengmarkS , NeuhausP . Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery ‐ results of a prospective trial. Zeitschrift für Gastroenterologie2002;40(10):869‐76. ">Rayes 2002</a>; <a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>). Two trials were free from for‐profit bias (<a href="./references#CD006660-bbs2-0003" title="HellingerWC , YaoJD , AlvarezS , BlairJE , CawleyJJ , PayaCV , et al. A randomized, prospective, double‐blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation2002;73(12):1904‐9. ">Hellinger 2002</a>; <a href="./references#CD006660-bbs2-0007" title="MaringJK , ZwavelingJH , KlompmakerIJ , van derMeerJ , SlooffMJ . Selective bowel decontamination in elective liver transplantation: no improvement in endotoxaemia, initial graft function and post‐operative morbidity. Transplant International2002;15(7):329‐34. ZwavelingJH , MaringJK , KlompmakerIJ , HaagsmaEB , BottemaJT , LaseurM , et al. Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo‐controlled trial in liver transplant patients. Critical Care Medicine2002;30(6):1204‐9. vanEnckevortPJ , ZwavelingJH , BottemaJT , MaringJK , KlompmakerIJ , SlooffMJH , et al. Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients. Pharmacoeconomics2001;19(5):523‐30. ">Zwaveling 2002</a>). Overall, only one trial was considered to be at low risk of bias (<a href="./references#CD006660-bbs2-0003" title="HellingerWC , YaoJD , AlvarezS , BlairJE , CawleyJJ , PayaCV , et al. A randomized, prospective, double‐blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation2002;73(12):1904‐9. ">Hellinger 2002</a>). </p> <div class="figure" id="CD006660-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006660-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD006660-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006660-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> </section> <section id="CD006660-sec-0066"> <h3 class="title" id="CD006660-sec-0066">Effects of interventions</h3> <p>See: <a href="./full#CD006660-tbl-0001"><b>Summary of findings for the main comparison</b> Intervention compared to control for people undergoing liver transplantation (mortality)</a>; <a href="./full#CD006660-tbl-0002"><b>Summary of findings 2</b> Intervention compared to control for people undergoing liver transplantation (retransplantation)</a> </p> <section id="CD006660-sec-0067"> <h4 class="title">Mortality</h4> <p>Mortality was reported in six trials (<a href="./references#CD006660-bbs2-0002" title="BadgerIL , CrosbyHA , KongKL , BakerJP , HutchingsP , ElliottTS , et al. Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplantation Proceedings1991;23(1 Part 2):1460‐1. BionJF , BadgerI , CrosbyHA , HutchingsP , KongKL , BakerJ , et al. Selective decontamination of the digestive tract reduces gram‐negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Critical Care Medicine1994;22(1):40‐9. ">Bion 1994</a>; <a href="./references#CD006660-bbs2-0006" title="WinstonDJ , FosterPF , SombergKA , BusuttilRW , LevyMF , SheinerPA , et al. Randomized, placebo‐controlled, double‐blind, multicenter trial of efficacy and safety of granulocyte colony‐stimulating factor in liver transplant recipients. Transplantation1999;68(9):1298‐304. ">Winston 1999</a>; <a href="./references#CD006660-bbs2-0003" title="HellingerWC , YaoJD , AlvarezS , BlairJE , CawleyJJ , PayaCV , et al. A randomized, prospective, double‐blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation2002;73(12):1904‐9. ">Hellinger 2002</a>; <a href="./references#CD006660-bbs2-0004" title="RayesN , BrammerM , HansenS , MuellerAR , SerkeS , SeehoferD , et al. Early enteral supply of lactobacilli and fiber versus SBD ‐ a prospective randomized trial in liver transplant recipients (abstract). Journal of Hepatology2001;34(1):199. RayesN , SeehoferD , HansenS , BoucseinK , MullerAR , SerkeS , et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation2002;74(1):123‐7. RayesN , SeehoferD , MullerAR , HansenS , BengmarkS , NeuhausP . Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery ‐ results of a prospective trial. Zeitschrift für Gastroenterologie2002;40(10):869‐76. ">Rayes 2002</a>; <a href="./references#CD006660-bbs2-0007" title="MaringJK , ZwavelingJH , KlompmakerIJ , van derMeerJ , SlooffMJ . Selective bowel decontamination in elective liver transplantation: no improvement in endotoxaemia, initial graft function and post‐operative morbidity. Transplant International2002;15(7):329‐34. ZwavelingJH , MaringJK , KlompmakerIJ , HaagsmaEB , BottemaJT , LaseurM , et al. Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo‐controlled trial in liver transplant patients. Critical Care Medicine2002;30(6):1204‐9. vanEnckevortPJ , ZwavelingJH , BottemaJT , MaringJK , KlompmakerIJ , SlooffMJH , et al. Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients. Pharmacoeconomics2001;19(5):523‐30. ">Zwaveling 2002</a>; <a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>), and all five comparisons (<a href="./references#CD006660-fig-0012" title="">Analysis 1.1</a>). The results are summarised in <a href="./full#CD006660-tbl-0001">summary of findings Table for the main comparison</a>. There was no significant difference in the proportion of participants who died between the intervention and the control groups for any of the comparisons. </p> <p> <ul id="CD006660-list-0012"> <li> <p>Selective bowel decontamination versus inactive control: RR 0.91; 95% CI 0.31 to 2.72.</p> </li> <li> <p>Selective bowel decontamination versus prebiotics with probiotics: not estimable (no mortality in either group). </p> </li> <li> <p>Selective bowel decontamination versus prebiotics: not estimable (no mortality in either group). </p> </li> <li> <p>Prebiotics with probiotics versus prebiotics: not estimable (no mortality in either group). </p> </li> <li> <p>G‐CSF versus control: RR 1.24; 95% CI 0.62 to 2.47.</p> </li> </ul> </p> <p>The results did not change by using the random‐effects model for the comparisons with two or more trials or by calculating the risk difference. Trial sequential analysis was performed for selective bowel decontamination versus inactive control and prebiotics with probiotics versus prebiotics, the only comparisons with at least two trials. Since there was no mortality in either group in the comparison prebiotics with probiotics versus prebiotics, the mortality in the control group in the selective bowel decontamination versus inactive control comparison was used for the trial sequential analysis calculations. The proportion of participants recruited was less than 2% of the DARIS and so trial sequential boundaries were not drawn. The conventional boundaries were not crossed (<a href="#CD006660-fig-0004">Figure 4</a>; <a href="#CD006660-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD006660-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Trial sequential analysis of mortality (selective bowel decontamination versus inactive control)     The diversity‐adjusted required information size (DARIS) was calculated to 9753 participants, based on the proportion of participants in the control group with the outcome of 6.8%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. To account for zero event groups, a continuity correction of 0.01 was used in the calculation of the cumulative Z‐curve (blue line). After accruing 190 participants in three trials, only 1.95% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have also not been crossed by the cumulative Z‐curve." data-id="CD006660-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial sequential analysis of mortality (selective bowel decontamination versus inactive control)</b> <br/> <br/> The diversity‐adjusted required information size (DARIS) was calculated to 9753 participants, based on the proportion of participants in the control group with the outcome of 6.8%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. To account for zero event groups, a continuity correction of 0.01 was used in the calculation of the cumulative Z‐curve (blue line). After accruing 190 participants in three trials, only 1.95% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have also not been crossed by the cumulative Z‐curve. </p> </div> </div> </div> <div class="figure" id="CD006660-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Trial sequential analysis of mortality (prebiotics with probiotics versus prebiotics)     The diversity‐adjusted required information size (DARIS) was calculated to 9753 participants, based on the proportion of participants in the control group with the outcome of 6.8%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. To account for zero event groups, a continuity correction of 0.01 was used in the calculation of the cumulative Z‐curve (blue line). After accruing 129 participants in two trials, only 1.32% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have also not been crossed by the cumulative Z‐curve." data-id="CD006660-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial sequential analysis of mortality (prebiotics with probiotics versus prebiotics)</b> <br/> <br/> The diversity‐adjusted required information size (DARIS) was calculated to 9753 participants, based on the proportion of participants in the control group with the outcome of 6.8%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. To account for zero event groups, a continuity correction of 0.01 was used in the calculation of the cumulative Z‐curve (blue line). After accruing 129 participants in two trials, only 1.32% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have also not been crossed by the cumulative Z‐curve. </p> </div> </div> </div> </section> <section id="CD006660-sec-0068"> <h4 class="title">Retransplantation</h4> <p>Retransplantation was reported in five trials (<a href="./references#CD006660-bbs2-0002" title="BadgerIL , CrosbyHA , KongKL , BakerJP , HutchingsP , ElliottTS , et al. Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplantation Proceedings1991;23(1 Part 2):1460‐1. BionJF , BadgerI , CrosbyHA , HutchingsP , KongKL , BakerJ , et al. Selective decontamination of the digestive tract reduces gram‐negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Critical Care Medicine1994;22(1):40‐9. ">Bion 1994</a>; <a href="./references#CD006660-bbs2-0006" title="WinstonDJ , FosterPF , SombergKA , BusuttilRW , LevyMF , SheinerPA , et al. Randomized, placebo‐controlled, double‐blind, multicenter trial of efficacy and safety of granulocyte colony‐stimulating factor in liver transplant recipients. Transplantation1999;68(9):1298‐304. ">Winston 1999</a>; <a href="./references#CD006660-bbs2-0003" title="HellingerWC , YaoJD , AlvarezS , BlairJE , CawleyJJ , PayaCV , et al. A randomized, prospective, double‐blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation2002;73(12):1904‐9. ">Hellinger 2002</a>; <a href="./references#CD006660-bbs2-0004" title="RayesN , BrammerM , HansenS , MuellerAR , SerkeS , SeehoferD , et al. Early enteral supply of lactobacilli and fiber versus SBD ‐ a prospective randomized trial in liver transplant recipients (abstract). Journal of Hepatology2001;34(1):199. RayesN , SeehoferD , HansenS , BoucseinK , MullerAR , SerkeS , et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation2002;74(1):123‐7. RayesN , SeehoferD , MullerAR , HansenS , BengmarkS , NeuhausP . Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery ‐ results of a prospective trial. Zeitschrift für Gastroenterologie2002;40(10):869‐76. ">Rayes 2002</a>; <a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>), and all five comparisons (<a href="./references#CD006660-fig-0013" title="">Analysis 1.2</a>). The results are summarised in <a href="./full#CD006660-tbl-0002">summary of findings Table 2</a>. There was no significant difference in the proportion of participants who required retransplantation between the intervention and control groups for any of the comparisons. </p> <p> <ul id="CD006660-list-0013"> <li> <p>Selective bowel decontamination versus inactive control: RR 0.85; 95% CI 0.26 to 2.85.</p> </li> <li> <p>Selective bowel decontamination versus prebiotics with probiotics: RR 2.91; 95% CI 0.12 to 68.81. </p> </li> <li> <p>Selective bowel decontamination versus prebiotics: RR 3.00; 95% CI 0.13 to 71.00.</p> </li> <li> <p>Prebiotics with probiotics versus prebiotics: RR 0.33; 95% CI 0.01 to 7.90.</p> </li> <li> <p>G‐CSF versus placebo: RR 1.13; 95% CI 0.40 to 3.17.</p> </li> </ul> </p> <p>The results did not change by using the random‐effects model for the comparisons with two or more trials or by calculating the risk difference. Trial sequential analysis was performed for selective bowel decontamination versus inactive control and prebiotics with probiotics versus prebiotics, the only two comparisons with at least two trials. The proportion of participants recruited was less than 2% of the DARIS and so the trial sequential boundaries were not drawn. The conventional boundaries were not crossed (<a href="#CD006660-fig-0006">Figure 6</a>; <a href="#CD006660-fig-0007">Figure 7</a>). </p> <div class="figure" id="CD006660-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Trial sequential analysis of retransplantation (selective bowel decontamination versus inactive control)     The diversity‐adjusted required information size (DARIS) was calculated to 8086 participants, based on the proportion of participants in the control group with the outcome of 8.1%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. To account for zero event groups, a continuity correction of 0.01 was used in the calculation of the cumulative Z‐curve (blue line). After accruing 132 participants in two trials, only 1.63% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have also not been crossed by the cumulative Z‐curve." data-id="CD006660-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial sequential analysis of retransplantation (selective bowel decontamination versus inactive control)</b> <br/> <br/> The diversity‐adjusted required information size (DARIS) was calculated to 8086 participants, based on the proportion of participants in the control group with the outcome of 8.1%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. To account for zero event groups, a continuity correction of 0.01 was used in the calculation of the cumulative Z‐curve (blue line). After accruing 132 participants in two trials, only 1.63% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have also not been crossed by the cumulative Z‐curve. </p> </div> </div> </div> <div class="figure" id="CD006660-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Trial sequential analysis of mortality (prebiotics with probiotics versus prebiotics)     The diversity‐adjusted required information size (DARIS) was calculated to 46,458 participants, based on the proportion of participants in the control group with the outcome of 1.5%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. To account for zero event groups, a continuity correction of 0.01 was used in the calculation of the cumulative Z‐curve (blue line). After accruing 129 participants in two trials, only 0.28% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have also not been crossed by the cumulative Z‐curve." data-id="CD006660-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial sequential analysis of mortality (prebiotics with probiotics versus prebiotics)</b> <br/> <br/> The diversity‐adjusted required information size (DARIS) was calculated to 46,458 participants, based on the proportion of participants in the control group with the outcome of 1.5%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. To account for zero event groups, a continuity correction of 0.01 was used in the calculation of the cumulative Z‐curve (blue line). After accruing 129 participants in two trials, only 0.28% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have also not been crossed by the cumulative Z‐curve. </p> </div> </div> </div> </section> <section id="CD006660-sec-0069"> <h4 class="title">Quality of life</h4> <p>Quality of life was not reported in any of the trials.</p> </section> <section id="CD006660-sec-0070"> <h4 class="title">Serious adverse events</h4> <p>The serious adverse events were not reported in sufficient details to calculate the proportion of patients who developed serious adverse events or the number of serious adverse events in the intervention and control groups. </p> </section> <section id="CD006660-sec-0071"> <h4 class="title">Graft rejection</h4> <p>Graft rejection requiring medical treatment was reported in two trials (<a href="./references#CD006660-bbs2-0006" title="WinstonDJ , FosterPF , SombergKA , BusuttilRW , LevyMF , SheinerPA , et al. Randomized, placebo‐controlled, double‐blind, multicenter trial of efficacy and safety of granulocyte colony‐stimulating factor in liver transplant recipients. Transplantation1999;68(9):1298‐304. ">Winston 1999</a>; <a href="./references#CD006660-bbs2-0004" title="RayesN , BrammerM , HansenS , MuellerAR , SerkeS , SeehoferD , et al. Early enteral supply of lactobacilli and fiber versus SBD ‐ a prospective randomized trial in liver transplant recipients (abstract). Journal of Hepatology2001;34(1):199. RayesN , SeehoferD , HansenS , BoucseinK , MullerAR , SerkeS , et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation2002;74(1):123‐7. RayesN , SeehoferD , MullerAR , HansenS , BengmarkS , NeuhausP . Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery ‐ results of a prospective trial. Zeitschrift für Gastroenterologie2002;40(10):869‐76. ">Rayes 2002</a>), and four comparisons (<a href="./references#CD006660-fig-0014" title="">Analysis 1.3</a>). There was no significant difference in the proportion of participants who developed graft rejection requiring medical treatment between the intervention and control groups for any of the comparisons. </p> <p> <ul id="CD006660-list-0014"> <li> <p>Selective bowel decontamination versus prebiotics with probiotics: RR 1.94; 95% CI 0.38 to 9.83. </p> </li> <li> <p>Selective bowel decontamination versus prebiotics: RR 1.33; 95% CI 0.32 to 5.49.</p> </li> <li> <p>Prebiotics with probiotics versus prebiotics: RR 0.69; 95% CI 0.12 to 3.84.</p> </li> <li> <p>G‐CSF versus placebo: RR 1.74; 95% CI 0.94 to 3.22.</p> </li> </ul> </p> <p>The results did not change by using the random‐effects model or by calculating the risk difference. Trial sequential analysis was not performed since none of the comparisons had more than one trial. </p> <p>Graft rejection was reported in three trials without specifying the treatment (<a href="./references#CD006660-bbs2-0002" title="BadgerIL , CrosbyHA , KongKL , BakerJP , HutchingsP , ElliottTS , et al. Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplantation Proceedings1991;23(1 Part 2):1460‐1. BionJF , BadgerI , CrosbyHA , HutchingsP , KongKL , BakerJ , et al. Selective decontamination of the digestive tract reduces gram‐negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Critical Care Medicine1994;22(1):40‐9. ">Bion 1994</a>; <a href="./references#CD006660-bbs2-0001" title="ArnowPM , CarandangGC , ZabnerR , IrwinME . Randomized controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clinical Infectious Diseases1996;22(6):997‐1003. ">Arnow 1996</a>; <a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>). This could be included in two comparisons (<a href="./references#CD006660-fig-0015" title="">Analysis 1.4</a>). There was no significant difference in the proportion of participants who developed graft rejection for which no treatment was specified between the intervention and control groups. </p> <p> <ul id="CD006660-list-0015"> <li> <p>Selective bowel decontamination versus inactive control: RR 1.09; 95% CI 0.85 to 1.38.</p> </li> <li> <p>Prebiotics with probiotics versus prebiotics: RR 0.86; 95% CI 0.32 to 2.28.</p> </li> </ul> </p> <p>The results did not change by using the random‐effects model for the comparisons with two or more trials or by calculating the risk difference. </p> </section> <section id="CD006660-sec-0072"> <h4 class="title">Infective complications</h4> <p>The proportion of participants who developed infective complications were reported in all the trials and all the five comparisons (<a href="./references#CD006660-fig-0016" title="">Analysis 1.5</a>). There was no significant difference in the proportion of participants who developed infective complications between the intervention and control groups for any of the comparisons except selective bowel decontamination versus prebiotics with probiotics. The proportion of participants who developed infective complications was significantly higher in the selective bowel decontamination group than the prebiotics with probiotics group. </p> <p> <ul id="CD006660-list-0016"> <li> <p>Selective bowel decontamination versus inactive control: RR 0.94; 95% CI 0.63 to 1.41.</p> </li> <li> <p>Selective bowel decontamination versus prebiotics with probiotics: RR 3.63; 95% CI 1.36 to 9.74. </p> </li> <li> <p>Selective bowel decontamination versus prebiotics: RR 1.36; 95% CI 0.75 to 2.50.</p> </li> <li> <p>Prebiotics with probiotics versus prebiotics: RR 0.18; 95% CI 0.03 to 1.17.</p> </li> <li> <p>G‐CSF versus control: RR 1.03; 95% CI 0.55 to 1.96.</p> </li> </ul> </p> <p>The results did not change by using the random‐effects model for the comparisons with two or more trials or by calculating the risk difference. The trial sequential analysis was performed for selective bowel decontamination versus inactive control and prebiotic with probiotics versus prebiotics, the only two comparisons with at least two trials. </p> <p>Trial sequential analysis of selective bowel decontamination versus inactive control revealed that neither the trial sequential boundaries nor the conventional boundaries were crossed by the cumulative Z‐line (<a href="#CD006660-fig-0008">Figure 8</a>). Trial sequential analysis of prebiotics with probiotics versus prebiotics revealed that the proportion of participants recruited was less than 2% of the DARIS and so the trial sequential boundaries were not drawn. The conventional boundaries were not crossed (<a href="#CD006660-fig-0009">Figure 9</a>). </p> <div class="figure" id="CD006660-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Trial sequential analysis of infection (selective bowel decontamination versus inactive control)     The diversity‐adjusted required information size (DARIS) was calculated to 2639 participants, based on the proportion of participants in the control group with the outcome of 44.9%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. After accruing 256 participants in four trials, only 9.7% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the futility area. The cumulative Z‐curve (blue line) does not cross the trial sequential monitoring boundaries (continuous red line) or the conventional boundaries (dotted red line)." data-id="CD006660-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial sequential analysis of infection (selective bowel decontamination versus inactive control)</b> <br/> <br/> The diversity‐adjusted required information size (DARIS) was calculated to 2639 participants, based on the proportion of participants in the control group with the outcome of 44.9%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. After accruing 256 participants in four trials, only 9.7% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the futility area. The cumulative Z‐curve (blue line) does not cross the trial sequential monitoring boundaries (continuous red line) or the conventional boundaries (dotted red line). </p> </div> </div> </div> <div class="figure" id="CD006660-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Trial sequential analysis of infection (prebiotics with probiotics versus prebiotics)     The diversity‐adjusted required information size (DARIS) was calculated to 3745 participants, based on the proportion of participants in the control group with the outcome of 41.5%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 71.51%. After accruing 129 participants in two trials, only 3.44% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have not been crossed by the cumulative Z‐curve (blue line) after two trials although the conventional boundary was crossed favouring probiotics with prebiotics after the first trial." data-id="CD006660-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG09.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial sequential analysis of infection (prebiotics with probiotics versus prebiotics)</b> <br/> <br/> The diversity‐adjusted required information size (DARIS) was calculated to 3745 participants, based on the proportion of participants in the control group with the outcome of 41.5%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 71.51%. After accruing 129 participants in two trials, only 3.44% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have not been crossed by the cumulative Z‐curve (blue line) after two trials although the conventional boundary was crossed favouring probiotics with prebiotics after the first trial. </p> </div> </div> </div> <p>The number of infection episodes were reported in three trials (<a href="./references#CD006660-bbs2-0002" title="BadgerIL , CrosbyHA , KongKL , BakerJP , HutchingsP , ElliottTS , et al. Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplantation Proceedings1991;23(1 Part 2):1460‐1. BionJF , BadgerI , CrosbyHA , HutchingsP , KongKL , BakerJ , et al. Selective decontamination of the digestive tract reduces gram‐negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Critical Care Medicine1994;22(1):40‐9. ">Bion 1994</a>; <a href="./references#CD006660-bbs2-0006" title="WinstonDJ , FosterPF , SombergKA , BusuttilRW , LevyMF , SheinerPA , et al. Randomized, placebo‐controlled, double‐blind, multicenter trial of efficacy and safety of granulocyte colony‐stimulating factor in liver transplant recipients. Transplantation1999;68(9):1298‐304. ">Winston 1999</a>; <a href="./references#CD006660-bbs2-0004" title="RayesN , BrammerM , HansenS , MuellerAR , SerkeS , SeehoferD , et al. Early enteral supply of lactobacilli and fiber versus SBD ‐ a prospective randomized trial in liver transplant recipients (abstract). Journal of Hepatology2001;34(1):199. RayesN , SeehoferD , HansenS , BoucseinK , MullerAR , SerkeS , et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation2002;74(1):123‐7. RayesN , SeehoferD , MullerAR , HansenS , BengmarkS , NeuhausP . Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery ‐ results of a prospective trial. Zeitschrift für Gastroenterologie2002;40(10):869‐76. ">Rayes 2002</a>), and four comparisons (<a href="./references#CD006660-fig-0017" title="">Analysis 1.6</a>). There was no significant difference in the number of infection episodes between the intervention and control groups for any of the comparisons except selective bowel decontamination versus prebiotics with probiotics. The number of infection episodes was significantly higher in the selective bowel decontamination group than prebiotics with probiotics group. </p> <p> <ul id="CD006660-list-0017"> <li> <p>Selective bowel decontamination versus inactive control: RaR 0.49; 95% CI 0.18 to 1.36. </p> </li> <li> <p>Selective bowel decontamination versus prebiotics with probiotics: RaR 5.58; 95% CI 1.94 to 16.09. </p> </li> <li> <p>Selective bowel decontamination versus prebiotics: RaR 1.35; 95% CI 0.72 to 2.53.</p> </li> <li> <p>Prebiotics with probiotics versus prebiotics: RaR 0.81; 95% CI 0.49 to 1.35.</p> </li> </ul> </p> <p>The issue of fixed‐effect versus random‐effects model did not arise because of the presence of only one trial for each comparison. </p> </section> <section id="CD006660-sec-0073"> <h4 class="title">Intensive therapy unit stay</h4> <p>The intensive therapy unit stay was reported in four trials (<a href="./references#CD006660-bbs2-0006" title="WinstonDJ , FosterPF , SombergKA , BusuttilRW , LevyMF , SheinerPA , et al. Randomized, placebo‐controlled, double‐blind, multicenter trial of efficacy and safety of granulocyte colony‐stimulating factor in liver transplant recipients. Transplantation1999;68(9):1298‐304. ">Winston 1999</a>; <a href="./references#CD006660-bbs2-0004" title="RayesN , BrammerM , HansenS , MuellerAR , SerkeS , SeehoferD , et al. Early enteral supply of lactobacilli and fiber versus SBD ‐ a prospective randomized trial in liver transplant recipients (abstract). Journal of Hepatology2001;34(1):199. RayesN , SeehoferD , HansenS , BoucseinK , MullerAR , SerkeS , et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation2002;74(1):123‐7. RayesN , SeehoferD , MullerAR , HansenS , BengmarkS , NeuhausP . Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery ‐ results of a prospective trial. Zeitschrift für Gastroenterologie2002;40(10):869‐76. ">Rayes 2002</a>; <a href="./references#CD006660-bbs2-0007" title="MaringJK , ZwavelingJH , KlompmakerIJ , van derMeerJ , SlooffMJ . Selective bowel decontamination in elective liver transplantation: no improvement in endotoxaemia, initial graft function and post‐operative morbidity. Transplant International2002;15(7):329‐34. ZwavelingJH , MaringJK , KlompmakerIJ , HaagsmaEB , BottemaJT , LaseurM , et al. Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo‐controlled trial in liver transplant patients. Critical Care Medicine2002;30(6):1204‐9. vanEnckevortPJ , ZwavelingJH , BottemaJT , MaringJK , KlompmakerIJ , SlooffMJH , et al. Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients. Pharmacoeconomics2001;19(5):523‐30. ">Zwaveling 2002</a>; <a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>), and in all five comparisons (<a href="./references#CD006660-fig-0018" title="">Analysis 1.7</a>). There was no significant difference in the Intensive therapy unit stay between the intervention and control groups for any of the comparisons. </p> <p> <ul id="CD006660-list-0018"> <li> <p>Selective bowel decontamination versus inactive control: MD 2.00 days; 95% CI ‐34.00 to 38.00. </p> </li> <li> <p>Selective bowel decontamination versus prebiotics with probiotics: MD 4.00 days; 95% CI ‐23.45 to 31.45. </p> </li> <li> <p>Selective bowel decontamination versus prebiotics: MD 2.20 days; 95% CI ‐31.12 to 35.52. </p> </li> <li> <p>Prebiotics with probiotics versus prebiotics: MD ‐1.41 days; 95% CI ‐5.30 to 2.49.</p> </li> <li> <p>G‐CSF versus control: MD 0.00 days; 95% CI ‐19.92 to 19.92.</p> </li> </ul> </p> <p>There was no change in results by using the random‐effects model for the comparisons with two or more trials. The standard deviation was imputed from the standard error in two trials (<a href="./references#CD006660-bbs2-0004" title="RayesN , BrammerM , HansenS , MuellerAR , SerkeS , SeehoferD , et al. Early enteral supply of lactobacilli and fiber versus SBD ‐ a prospective randomized trial in liver transplant recipients (abstract). Journal of Hepatology2001;34(1):199. RayesN , SeehoferD , HansenS , BoucseinK , MullerAR , SerkeS , et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation2002;74(1):123‐7. RayesN , SeehoferD , MullerAR , HansenS , BengmarkS , NeuhausP . Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery ‐ results of a prospective trial. Zeitschrift für Gastroenterologie2002;40(10):869‐76. ">Rayes 2002</a>; <a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>). In the remaining two trials, there were no details to calculate the standard deviation and the highest standard deviation in the comparisons was used (<a href="./references#CD006660-bbs2-0006" title="WinstonDJ , FosterPF , SombergKA , BusuttilRW , LevyMF , SheinerPA , et al. Randomized, placebo‐controlled, double‐blind, multicenter trial of efficacy and safety of granulocyte colony‐stimulating factor in liver transplant recipients. Transplantation1999;68(9):1298‐304. ">Winston 1999</a>; <a href="./references#CD006660-bbs2-0007" title="MaringJK , ZwavelingJH , KlompmakerIJ , van derMeerJ , SlooffMJ . Selective bowel decontamination in elective liver transplantation: no improvement in endotoxaemia, initial graft function and post‐operative morbidity. Transplant International2002;15(7):329‐34. ZwavelingJH , MaringJK , KlompmakerIJ , HaagsmaEB , BottemaJT , LaseurM , et al. Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo‐controlled trial in liver transplant patients. Critical Care Medicine2002;30(6):1204‐9. vanEnckevortPJ , ZwavelingJH , BottemaJT , MaringJK , KlompmakerIJ , SlooffMJH , et al. Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients. Pharmacoeconomics2001;19(5):523‐30. ">Zwaveling 2002</a>). Therefore, we did not perform a sensitivity analysis excluding the trials in which standard deviation was imputed. Trial sequential analysis was performed only for the comparison between prebiotics with probiotics versus probiotics since this was the only comparison with more than two trials. The proportion of participants recruited was less than 2% of the DARIS and so the trial sequential boundaries were not drawn. The conventional boundaries were not crossed (<a href="#CD006660-fig-0010">Figure 10</a>). </p> <div class="figure" id="CD006660-fig-0010"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 10</div> </div> <hr class="top"/><img alt="Trial sequential analysis of intensive therapy unit stay (prebiotics with probiotics versus prebiotics)     The diversity‐adjusted required information size (DARIS) was 8005 participants based on a minimal relevant difference (MIRD) of 1 day, a variance (VAR) of 254.96, an alpha (a) of 5%, a beta (b) of 20%, and a diversity (D2) of 0%. After accruing 129 participants in two trials, only 1.61% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have not been crossed by the cumulative Z‐curve (blue line)." data-id="CD006660-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG10.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial sequential analysis of intensive therapy unit stay (prebiotics with probiotics versus prebiotics)</b> <br/> <br/> The diversity‐adjusted required information size (DARIS) was 8005 participants based on a minimal relevant difference (MIRD) of 1 day, a variance (VAR) of 254.96, an alpha (a) of 5%, a beta (b) of 20%, and a diversity (D<sup>2</sup>) of 0%. After accruing 129 participants in two trials, only 1.61% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have not been crossed by the cumulative Z‐curve (blue line). </p> </div> </div> </div> </section> <section id="CD006660-sec-0074"> <h4 class="title">Hospital stay</h4> <p>The hospital stay was reported in four trials (<a href="./references#CD006660-bbs2-0002" title="BadgerIL , CrosbyHA , KongKL , BakerJP , HutchingsP , ElliottTS , et al. Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplantation Proceedings1991;23(1 Part 2):1460‐1. BionJF , BadgerI , CrosbyHA , HutchingsP , KongKL , BakerJ , et al. Selective decontamination of the digestive tract reduces gram‐negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Critical Care Medicine1994;22(1):40‐9. ">Bion 1994</a>; <a href="./references#CD006660-bbs2-0006" title="WinstonDJ , FosterPF , SombergKA , BusuttilRW , LevyMF , SheinerPA , et al. Randomized, placebo‐controlled, double‐blind, multicenter trial of efficacy and safety of granulocyte colony‐stimulating factor in liver transplant recipients. Transplantation1999;68(9):1298‐304. ">Winston 1999</a>; <a href="./references#CD006660-bbs2-0004" title="RayesN , BrammerM , HansenS , MuellerAR , SerkeS , SeehoferD , et al. Early enteral supply of lactobacilli and fiber versus SBD ‐ a prospective randomized trial in liver transplant recipients (abstract). Journal of Hepatology2001;34(1):199. RayesN , SeehoferD , HansenS , BoucseinK , MullerAR , SerkeS , et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation2002;74(1):123‐7. RayesN , SeehoferD , MullerAR , HansenS , BengmarkS , NeuhausP . Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery ‐ results of a prospective trial. Zeitschrift für Gastroenterologie2002;40(10):869‐76. ">Rayes 2002</a>; <a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>), and in all five comparisons (<a href="./references#CD006660-fig-0019" title="">Analysis 1.8</a>). There was no significant difference in the hospital stay between the intervention and control groups for any of the comparisons. </p> <p> <ul id="CD006660-list-0019"> <li> <p>Selective bowel decontamination versus inactive control: MD 0.60 days; 95% CI ‐7.71 to 8.91. </p> </li> <li> <p>Selective bowel decontamination versus prebiotics with probiotics: MD 4.00 days; 95% CI ‐0.82 to 8.82. </p> </li> <li> <p>Selective bowel decontamination versus prebiotics: MD 3.00 days; 95% CI ‐2.39 to 8.39.</p> </li> <li> <p>Prebiotics with probiotics versus prebiotics: MD ‐0.49 days; 95% CI ‐5.19 to 4.20.</p> </li> <li> <p>G‐CSF versus control: MD 0.00 days; 95% CI ‐5.13 to 5.13.</p> </li> </ul> </p> <p>There was no change in results by using the random‐effects model for the comparisons with two or more trials. The standard deviation was imputed from the standard error in two trials (<a href="./references#CD006660-bbs2-0004" title="RayesN , BrammerM , HansenS , MuellerAR , SerkeS , SeehoferD , et al. Early enteral supply of lactobacilli and fiber versus SBD ‐ a prospective randomized trial in liver transplant recipients (abstract). Journal of Hepatology2001;34(1):199. RayesN , SeehoferD , HansenS , BoucseinK , MullerAR , SerkeS , et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation2002;74(1):123‐7. RayesN , SeehoferD , MullerAR , HansenS , BengmarkS , NeuhausP . Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery ‐ results of a prospective trial. Zeitschrift für Gastroenterologie2002;40(10):869‐76. ">Rayes 2002</a>; <a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>). In one of the remaining two trials, there were no details to calculate the standard deviation and the highest standard deviation in the comparisons was used (<a href="./references#CD006660-bbs2-0006" title="WinstonDJ , FosterPF , SombergKA , BusuttilRW , LevyMF , SheinerPA , et al. Randomized, placebo‐controlled, double‐blind, multicenter trial of efficacy and safety of granulocyte colony‐stimulating factor in liver transplant recipients. Transplantation1999;68(9):1298‐304. ">Winston 1999</a>). Therefore, we did not perform a sensitivity analysis excluding the trials in which standard deviation was imputed. Trial sequential analysis was performed only for the comparison between prebiotics with probiotics versus probiotics since this was the only comparison with more than two trials. The proportion of participants recruited was less than 2% of the DARIS and so the trial sequential boundaries were not drawn. The conventional boundaries were not crossed (<a href="#CD006660-fig-0011">Figure 11</a>). </p> <div class="figure" id="CD006660-fig-0011"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 11</div> </div> <hr class="top"/><img alt="Trial sequential analysis of hospital stay (prebiotics with probiotics versus prebiotics)     The diversity‐adjusted required information size (DARIS) was 11,621 participants based on a minimal relevant difference (MIRD) of 1 day, a variance (VAR) of 370.14, an alpha (a) of 5%, a beta (b) of 20%, and a diversity (D2) of 0%. After accruing 129 participants in two trials, only 1.11% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have not been crossed by the cumulative Z‐curve (blue line)." data-id="CD006660-fig-0011" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG11.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p><b>Trial sequential analysis of hospital stay (prebiotics with probiotics versus prebiotics)</b> <br/> <br/> The diversity‐adjusted required information size (DARIS) was 11,621 participants based on a minimal relevant difference (MIRD) of 1 day, a variance (VAR) of 370.14, an alpha (a) of 5%, a beta (b) of 20%, and a diversity (D<sup>2</sup>) of 0%. After accruing 129 participants in two trials, only 1.11% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have not been crossed by the cumulative Z‐curve (blue line). </p> </div> </div> </div> </section> <section id="CD006660-sec-0075"> <h4 class="title">Subgroup analysis</h4> <p>We did not perform any of the subgroup analyses because only one of the trials was of low risk of bias (<a href="./references#CD006660-bbs2-0003" title="HellingerWC , YaoJD , AlvarezS , BlairJE , CawleyJJ , PayaCV , et al. A randomized, prospective, double‐blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation2002;73(12):1904‐9. ">Hellinger 2002</a>), and too few trials were included under each outcome for the other subgroups. </p> </section> <section id="CD006660-sec-0076"> <h4 class="title">Reporting bias</h4> <p>We did not explore reporting bias with a funnel plot because of the presence of fewer than 10 trials for each comparison. </p> </section> <section id="CD006660-sec-0077"> <h4 class="title">'Summary of findings' tables</h4> <p>We have provided the 'Summary of findings' tables for mortality and retransplantation using GRADEpro (<a href="http://ims.cochrane.org/revman/other-resources/gradepro" target="_blank">ims.cochrane.org/revman/other‐resources/gradepro</a>). Because of the high number of outcomes and the high number of comparisons, we have not presented the other outcomes in 'Summary of findings' tables. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006660-sec-0078" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006660-sec-0078"></div> <section id="CD006660-sec-0079"> <h3 class="title" id="CD006660-sec-0079">Summary of main results</h3> <p>This systematic review revealed that there is no clear evidence supporting any of the evaluated interventions and that selective bowel decontamination may increase infections compared with a combination of prebiotics with probiotics. </p> <p>Previous systematic reviews assessing the role of selective bowel decontamination in critical care found a benefit of selective bowel decontamination in decreasing chest infection and hospital mortality (<a href="./references#CD006660-bbs2-0061" title="SchulzKF , ChalmersI , HayesRJ , AltmanDG . Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA1995;273(5):408‐12. ">Schulz 1995</a>). Selective bowel decontamination appears to be of no significant benefit in people undergoing liver transplantation. In addition, people need very high motivation if they have to take the antibiotics continuously for many months or even years, while they are waiting for the availability of donor. Even in the trial that started the selective bowel decontamination just at the time of organ donor availability, the medicines frequently reached expiry date and had to be continually replaced (<a href="./references#CD006660-bbs2-0002" title="BadgerIL , CrosbyHA , KongKL , BakerJP , HutchingsP , ElliottTS , et al. Is selective decontamination of the digestive tract beneficial in liver transplant patients? Interim results of a prospective, randomized trial. Transplantation Proceedings1991;23(1 Part 2):1460‐1. BionJF , BadgerI , CrosbyHA , HutchingsP , KongKL , BakerJ , et al. Selective decontamination of the digestive tract reduces gram‐negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Critical Care Medicine1994;22(1):40‐9. ">Bion 1994</a>). Thus, selective bowel decontamination requires highly motivated healthcare providers and participants. Poor patient compliance could be one reason for the lack of beneficial effect from selective bowel decontamination. Patient compliance was not reported in any of the trials. Other possible reasons for the lack of beneficial effect of selective bowel decontamination include development of microbial tolerance to these antibiotics due to prolonged use (assuming good patient compliance) and lack of efficacy of antibiotics. The only quasi‐randomised trial identified reported six participants with diarrhoea out of the 18 participants who received selective bowel decontamination (<a href="./references#CD006660-bbs2-0014" title="SmithSD , JacksonRJ , HannakanCJ , WadowskyRM , TzakisAG , RoweMI . Selective decontamination in pediatric liver transplants. A randomized prospective study. Transplantation1993;55(6):1306‐9. ">Smith 1993</a>). None of these people had pseudomembranous colitis. The prevalence of diarrhoea in the control group was not stated and so the outcome could not be included in a meta‐analysis. </p> <p>The use of prebiotics with probiotics appears to decrease the number of people with any bacterial infection compared with selective bowel decontamination. However, only one trial assessed this comparison. Using lactobacillus in addition to fibres (prebiotics with probiotics) did not increase the abdominal cramps or diarrhoea (adverse effects due to the use of fibres) when compared with fibres alone. However, there was no comparison of these adverse effects with placebo. Therefore, it is unclear whether the use of prebiotics with probiotics causes discomfort to the patients. There are no direct comparisons of prebiotics either alone or in combination with probiotics versus placebo. Because of the heterogeneity in the treatments used to achieve selective bowel decontamination, it is not possible to use indirect comparisons to provide an estimate of the beneficial effect due to prebiotics alone or in combination with probiotics over no intervention. It should also be pointed out that there have been reports about infective complications such as abscesses due to Lactobacillus as a result of the use of probiotics (<a href="./references#CD006660-bbs2-0055" title="RautioM , Jousimies‐SomerH , KaumaH , PietarinenI , SaxelinM , TynkkynenS , et al. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clinical Infectious Diseases1999;28(5):1159‐60. ">Rautio 1999</a>; <a href="./references#CD006660-bbs2-0027" title="DeGrooteMA , FrankDN , DowellE , GlodeMP , PaceNR . Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatric Infectious Disease Journal2005;24(3):278‐80. ">De Groote 2005</a>). Therefore, the use of probiotics in people undergoing liver transplantation who receive immunosuppression should be further evaluated before such routine recommendations are given. </p> <p>There was no beneficial effect of G‐CSF in reducing infections. Rejection and retransplantation are relevant in this comparison, as G‐CSF modulates the immune system. Although there was no significant difference in rejection after G‐CSF versus placebo, the CIs were wide and it was impossible to determine whether this lack of significant observed difference was because of lack of effect or lack of evidence of effect. G‐CSF does not appear to be safe and in the absence of any evidence of decreased complications, there appears to be no reason in using G‐CSF. </p> <p>None of the trials investigated the relationship between the incidence of the infective complications and patient variables (such as pre‐operative MELD score, reason for liver transplantation, duration of pre‐operative hospital stay) or donor variables (such as donor instability at retrieval, donor infections at retrieval) that could potentially influence the results. It is possible that some interventions work in some groups of people and not in others. </p> </section> <section id="CD006660-sec-0080"> <h3 class="title" id="CD006660-sec-0080">Overall completeness and applicability of evidence</h3> <p>Most of the trials included adults undergoing elective liver transplantation. Therefore, this evidence is applicable only in adults undergoing elective liver transplantation. It should be noted that the selection of participants undergoing liver transplantation was based on the pre‐MELD era, and it is not clear whether the evidence is applicable for people in the MELD era. However, it must be pointed out that some studies state that there is no significant difference in the prediction of prognosis between MELD and Child‐Turcotte‐Pugh scores (<a href="./references#CD006660-bbs2-0024" title="CholongitasE , MarelliL , ShusangV , SenzoloM , RollesK , PatchD , et al. A systematic review of the performance of the model for end‐stage liver disease (MELD) in the setting of liver transplantation. Liver Transplantation2006;12(7):1049‐61. ">Cholongitas 2006</a>), while other studies showed that the results were better in the post‐MELD era (<a href="./references#CD006660-bbs2-0016" title="AgopianVG , PetrowskyH , KaldasFM , ZarrinparA , FarmerDG , YersizH , et al. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center. Annals of Surgery2013;258(3):409‐21. ">Agopian 2013</a>). Most of the trials included in this review are more than 10 years old and the survival has improved significantly since the mid‐2000s despite riskier patients receiving transplants (<a href="./references#CD006660-bbs2-0016" title="AgopianVG , PetrowskyH , KaldasFM , ZarrinparA , FarmerDG , YersizH , et al. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center. Annals of Surgery2013;258(3):409‐21. ">Agopian 2013</a>). Therefore, it is unclear whether the results of this review are applicable in the current era of liver transplantation. It should also be noted that all the participants in the trials included in this review received antibiotics, and so the findings of this review are applicable only to people who receive antibiotic prophylaxis when they undergo liver transplantation. In addition, none of the trials compared different antibiotic regimens or compared antibiotic prophylaxis versus no antibiotic prophylaxis. While trials comparing different antibiotic regimens can be conducted, the ethical nature of antibiotic prophylaxis versus no antibiotic prophylaxis in people undergoing liver transplantation is debatable since people undergoing liver transplantation routinely receive immunosuppression and the intact digestive tract is breached (the donor bile duct is anastomosed to the recipient bile duct) and antibiotic prophylaxis is recommended in both these situations (<a href="./references#CD006660-bbs2-0020" title="BratzlerDW , DellingerEP , OlsenKM , PerlTM , AuwaerterPG , BolonMK , et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. American Journal of Health‐system Pharmacy2013;70(3):195‐283. ">Bratzler 2013</a>). Even with antibiotic prophylaxis, about one‐third of people develop infective complications. </p> </section> <section id="CD006660-sec-0081"> <h3 class="title" id="CD006660-sec-0081">Quality of the evidence</h3> <p>Most of the trials were of high risk of bias. Many of the trials had significant withdrawals or drop‐outs. For some interventions that require prolonged period of the intervention (such as prolonged period of antibiotics for selective bowel decontamination) and a long wait for liver transplantation, there will be withdrawals or drop‐outs. It is debatable whether to use intention‐to‐treat analysis or available‐case analysis for deaths during the waiting period or during the operation (with both methods of analysis having advantages and disadvantages), particularly if the deaths (unrelated to intervention) were more in one group. However, intention‐to‐treat analysis should be used if the withdrawal is due to intolerance to the intervention. Most of the trials in this review excluded these participants from the analysis. Future trials should perform intention‐to‐treat analyses. </p> <p>In many of the trials, it is possible to blind the participants, healthcare providers, and outcome assessors to the intervention being administered. However, only four of the seven trials performed this (<a href="./references#CD006660-bbs2-0006" title="WinstonDJ , FosterPF , SombergKA , BusuttilRW , LevyMF , SheinerPA , et al. Randomized, placebo‐controlled, double‐blind, multicenter trial of efficacy and safety of granulocyte colony‐stimulating factor in liver transplant recipients. Transplantation1999;68(9):1298‐304. ">Winston 1999</a>; <a href="./references#CD006660-bbs2-0003" title="HellingerWC , YaoJD , AlvarezS , BlairJE , CawleyJJ , PayaCV , et al. A randomized, prospective, double‐blinded evaluation of selective bowel decontamination in liver transplantation. Transplantation2002;73(12):1904‐9. ">Hellinger 2002</a>; <a href="./references#CD006660-bbs2-0007" title="MaringJK , ZwavelingJH , KlompmakerIJ , van derMeerJ , SlooffMJ . Selective bowel decontamination in elective liver transplantation: no improvement in endotoxaemia, initial graft function and post‐operative morbidity. Transplant International2002;15(7):329‐34. ZwavelingJH , MaringJK , KlompmakerIJ , HaagsmaEB , BottemaJT , LaseurM , et al. Selective decontamination of the digestive tract to prevent postoperative infection: a randomized placebo‐controlled trial in liver transplant patients. Critical Care Medicine2002;30(6):1204‐9. vanEnckevortPJ , ZwavelingJH , BottemaJT , MaringJK , KlompmakerIJ , SlooffMJH , et al. Cost effectiveness of selective decontamination of the digestive tract in liver transplant patients. Pharmacoeconomics2001;19(5):523‐30. ">Zwaveling 2002</a>; <a href="./references#CD006660-bbs2-0005" title="RayesN , SeehoferD , TheruvathT , SchillerRA , LangrehrJM , JonasS , et al. Supply of pre‐ and probiotics reduces bacterial infection rates after liver transplantation ‐ a randomized, double‐blind trial. American Journal of Transplantation2005;5(1):125‐30. ">Rayes 2005</a>). Blinding should be performed to obtain a better estimate of the true effect of the intervention (<a href="./references#CD006660-bbs2-0061" title="SchulzKF , ChalmersI , HayesRJ , AltmanDG . Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA1995;273(5):408‐12. ">Schulz 1995</a>; <a href="./references#CD006660-bbs2-0042" title="KjaergardLL , VillumsenJ , GluudC . Reported methodologic quality and discrepancies between large and small randomized trials in meta‐analyses. Annals of Internal Medicine2001;135(11):982‐9. ">Kjaergard 2001</a>; <a href="./references#CD006660-bbs2-0071" title="WoodL , EggerM , GluudLL , SchulzKF , JüniP , AltmanGD , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ (Clinical Research Ed.)2008;336:601‐5. ">Wood 2008</a>; <a href="./references#CD006660-bbs2-0059" title="SavovićJ , JonesHE , AltmanDG , HarrisRJ , JüniP , PildalJ , et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Health Technology Assessment2012;16(35):1‐82. ">Savović 2012</a>; <a href="./references#CD006660-bbs2-0060" title="SavovićJ , JonesHE , AltmanDG , HarrisRJ , JüniP , PildalJ , et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine2012;157(6):429‐38. ">Savović 2012a</a>). </p> <p>Overall, the quality of evidence was very low as indicated in <a href="./full#CD006660-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD006660-tbl-0002">summary of findings Table 2</a>. However, it must be pointed out that this is the best evidence available on this topic currently. </p> </section> <section id="CD006660-sec-0082"> <h3 class="title" id="CD006660-sec-0082">Potential biases in the review process</h3> <p>We evaluated a heterogeneous group of trials and decided not to include a number of interventions, for example, nutrition or procedure‐related interventions. Other systematic reviews ought to assess the benefits and harms of such interventions. </p> </section> <section id="CD006660-sec-0083"> <h3 class="title" id="CD006660-sec-0083">Agreements and disagreements with other studies or reviews</h3> <p>This review broadly agrees with the previous version of our review (<a href="./references#CD006660-bbs2-0072" title="GurusamyKS , KumarY , DavidsonBR . Methods of preventing bacterial sepsis and wound complications for liver transplantation. Cochrane Database of Systematic Reviews2008, Issue 4. [DOI: 10.1002/14651858.CD006660.pub2] ">Gurusamy 2008</a>). We do not agree with another systematic review, which suggested that selective bowel decontamination is beneficial in decreasing gram‐negative infections (<a href="./references#CD006660-bbs2-0058" title="SafdarN , SaidA , LuceyMR . The role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: a systematic review and meta‐analysis. Liver Transplantation2004;10(7):817‐27. ">Safdar 2004</a>). However, the review also mentioned that selective bowel decontamination can increase gram‐positive cocci and suggested a cautious approach (<a href="./references#CD006660-bbs2-0058" title="SafdarN , SaidA , LuceyMR . The role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: a systematic review and meta‐analysis. Liver Transplantation2004;10(7):817‐27. ">Safdar 2004</a>). In our review, we gave more importance to the clinical implications of infections rather than the presence or absence of an infective microorganism in order to arrive at our conclusion. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006660-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/urn:x-wiley:14651858:media:CD006660:CD006660-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_t/tCD006660-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD006660-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006660-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/urn:x-wiley:14651858:media:CD006660:CD006660-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_t/tCD006660-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006660-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006660-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/urn:x-wiley:14651858:media:CD006660:CD006660-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_t/tCD006660-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD006660-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006660-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/urn:x-wiley:14651858:media:CD006660:CD006660-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_t/tCD006660-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Trial sequential analysis of mortality (selective bowel decontamination versus inactive control)     The diversity‐adjusted required information size (DARIS) was calculated to 9753 participants, based on the proportion of participants in the control group with the outcome of 6.8%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. To account for zero event groups, a continuity correction of 0.01 was used in the calculation of the cumulative Z‐curve (blue line). After accruing 190 participants in three trials, only 1.95% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have also not been crossed by the cumulative Z‐curve." data-id="CD006660-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p><b>Trial sequential analysis of mortality (selective bowel decontamination versus inactive control)</b> <br/> <br/> The diversity‐adjusted required information size (DARIS) was calculated to 9753 participants, based on the proportion of participants in the control group with the outcome of 6.8%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. To account for zero event groups, a continuity correction of 0.01 was used in the calculation of the cumulative Z‐curve (blue line). After accruing 190 participants in three trials, only 1.95% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have also not been crossed by the cumulative Z‐curve. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006660-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/urn:x-wiley:14651858:media:CD006660:CD006660-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_t/tCD006660-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Trial sequential analysis of mortality (prebiotics with probiotics versus prebiotics)     The diversity‐adjusted required information size (DARIS) was calculated to 9753 participants, based on the proportion of participants in the control group with the outcome of 6.8%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. To account for zero event groups, a continuity correction of 0.01 was used in the calculation of the cumulative Z‐curve (blue line). After accruing 129 participants in two trials, only 1.32% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have also not been crossed by the cumulative Z‐curve." data-id="CD006660-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p><b>Trial sequential analysis of mortality (prebiotics with probiotics versus prebiotics)</b> <br/> <br/> The diversity‐adjusted required information size (DARIS) was calculated to 9753 participants, based on the proportion of participants in the control group with the outcome of 6.8%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. To account for zero event groups, a continuity correction of 0.01 was used in the calculation of the cumulative Z‐curve (blue line). After accruing 129 participants in two trials, only 1.32% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have also not been crossed by the cumulative Z‐curve. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006660-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/urn:x-wiley:14651858:media:CD006660:CD006660-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_t/tCD006660-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Trial sequential analysis of retransplantation (selective bowel decontamination versus inactive control)     The diversity‐adjusted required information size (DARIS) was calculated to 8086 participants, based on the proportion of participants in the control group with the outcome of 8.1%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. To account for zero event groups, a continuity correction of 0.01 was used in the calculation of the cumulative Z‐curve (blue line). After accruing 132 participants in two trials, only 1.63% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have also not been crossed by the cumulative Z‐curve." data-id="CD006660-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p><b>Trial sequential analysis of retransplantation (selective bowel decontamination versus inactive control)</b> <br/> <br/> The diversity‐adjusted required information size (DARIS) was calculated to 8086 participants, based on the proportion of participants in the control group with the outcome of 8.1%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. To account for zero event groups, a continuity correction of 0.01 was used in the calculation of the cumulative Z‐curve (blue line). After accruing 132 participants in two trials, only 1.63% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have also not been crossed by the cumulative Z‐curve. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006660-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/urn:x-wiley:14651858:media:CD006660:CD006660-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_t/tCD006660-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Trial sequential analysis of mortality (prebiotics with probiotics versus prebiotics)     The diversity‐adjusted required information size (DARIS) was calculated to 46,458 participants, based on the proportion of participants in the control group with the outcome of 1.5%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. To account for zero event groups, a continuity correction of 0.01 was used in the calculation of the cumulative Z‐curve (blue line). After accruing 129 participants in two trials, only 0.28% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have also not been crossed by the cumulative Z‐curve." data-id="CD006660-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p><b>Trial sequential analysis of mortality (prebiotics with probiotics versus prebiotics)</b> <br/> <br/> The diversity‐adjusted required information size (DARIS) was calculated to 46,458 participants, based on the proportion of participants in the control group with the outcome of 1.5%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. To account for zero event groups, a continuity correction of 0.01 was used in the calculation of the cumulative Z‐curve (blue line). After accruing 129 participants in two trials, only 0.28% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have also not been crossed by the cumulative Z‐curve. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006660-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/urn:x-wiley:14651858:media:CD006660:CD006660-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_t/tCD006660-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Trial sequential analysis of infection (selective bowel decontamination versus inactive control)     The diversity‐adjusted required information size (DARIS) was calculated to 2639 participants, based on the proportion of participants in the control group with the outcome of 44.9%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. After accruing 256 participants in four trials, only 9.7% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the futility area. The cumulative Z‐curve (blue line) does not cross the trial sequential monitoring boundaries (continuous red line) or the conventional boundaries (dotted red line)." data-id="CD006660-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p><b>Trial sequential analysis of infection (selective bowel decontamination versus inactive control)</b> <br/> <br/> The diversity‐adjusted required information size (DARIS) was calculated to 2639 participants, based on the proportion of participants in the control group with the outcome of 44.9%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 0%. After accruing 256 participants in four trials, only 9.7% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the futility area. The cumulative Z‐curve (blue line) does not cross the trial sequential monitoring boundaries (continuous red line) or the conventional boundaries (dotted red line). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006660-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/urn:x-wiley:14651858:media:CD006660:CD006660-AFig-FIG09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_t/tCD006660-AFig-FIG09.png" target="_blank"><b></b></a></p> </div><img alt="Trial sequential analysis of infection (prebiotics with probiotics versus prebiotics)     The diversity‐adjusted required information size (DARIS) was calculated to 3745 participants, based on the proportion of participants in the control group with the outcome of 41.5%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 71.51%. After accruing 129 participants in two trials, only 3.44% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have not been crossed by the cumulative Z‐curve (blue line) after two trials although the conventional boundary was crossed favouring probiotics with prebiotics after the first trial." data-id="CD006660-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p><b>Trial sequential analysis of infection (prebiotics with probiotics versus prebiotics)</b> <br/> <br/> The diversity‐adjusted required information size (DARIS) was calculated to 3745 participants, based on the proportion of participants in the control group with the outcome of 41.5%, a relative risk reduction of 20%, an alpha of 5%, a beta of 20%, and a diversity of 71.51%. After accruing 129 participants in two trials, only 3.44% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have not been crossed by the cumulative Z‐curve (blue line) after two trials although the conventional boundary was crossed favouring probiotics with prebiotics after the first trial. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006660-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/urn:x-wiley:14651858:media:CD006660:CD006660-AFig-FIG10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_t/tCD006660-AFig-FIG10.png" target="_blank"><b></b></a></p> </div><img alt="Trial sequential analysis of intensive therapy unit stay (prebiotics with probiotics versus prebiotics)     The diversity‐adjusted required information size (DARIS) was 8005 participants based on a minimal relevant difference (MIRD) of 1 day, a variance (VAR) of 254.96, an alpha (a) of 5%, a beta (b) of 20%, and a diversity (D2) of 0%. After accruing 129 participants in two trials, only 1.61% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have not been crossed by the cumulative Z‐curve (blue line)." data-id="CD006660-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> <div class="figure-caption"> <p><b>Trial sequential analysis of intensive therapy unit stay (prebiotics with probiotics versus prebiotics)</b> <br/> <br/> The diversity‐adjusted required information size (DARIS) was 8005 participants based on a minimal relevant difference (MIRD) of 1 day, a variance (VAR) of 254.96, an alpha (a) of 5%, a beta (b) of 20%, and a diversity (D<sup>2</sup>) of 0%. After accruing 129 participants in two trials, only 1.61% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have not been crossed by the cumulative Z‐curve (blue line). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006660-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/urn:x-wiley:14651858:media:CD006660:CD006660-AFig-FIG11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_t/tCD006660-AFig-FIG11.png" target="_blank"><b></b></a></p> </div><img alt="Trial sequential analysis of hospital stay (prebiotics with probiotics versus prebiotics)     The diversity‐adjusted required information size (DARIS) was 11,621 participants based on a minimal relevant difference (MIRD) of 1 day, a variance (VAR) of 370.14, an alpha (a) of 5%, a beta (b) of 20%, and a diversity (D2) of 0%. After accruing 129 participants in two trials, only 1.11% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have not been crossed by the cumulative Z‐curve (blue line)." data-id="CD006660-fig-0011" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 11</div> <div class="figure-caption"> <p><b>Trial sequential analysis of hospital stay (prebiotics with probiotics versus prebiotics)</b> <br/> <br/> The diversity‐adjusted required information size (DARIS) was 11,621 participants based on a minimal relevant difference (MIRD) of 1 day, a variance (VAR) of 370.14, an alpha (a) of 5%, a beta (b) of 20%, and a diversity (D<sup>2</sup>) of 0%. After accruing 129 participants in two trials, only 1.11% of the DARIS has been reached. Accordingly, the trial sequential analysis does not show the required information size and the trial sequential monitoring boundaries. As shown, the conventional boundaries (dotted red line) have not been crossed by the cumulative Z‐curve (blue line). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-AFig-FIG11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006660-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/urn:x-wiley:14651858:media:CD006660:CD006660-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_t/tCD006660-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intervention versus control, Outcome 1 Mortality." data-id="CD006660-fig-0012" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Intervention versus control, Outcome 1 Mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/references#CD006660-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006660-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/urn:x-wiley:14651858:media:CD006660:CD006660-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_t/tCD006660-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intervention versus control, Outcome 2 Retransplantation." data-id="CD006660-fig-0013" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Intervention versus control, Outcome 2 Retransplantation.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/references#CD006660-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006660-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/urn:x-wiley:14651858:media:CD006660:CD006660-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_t/tCD006660-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intervention versus control, Outcome 3 Graft rejection requiring medical treatment." data-id="CD006660-fig-0014" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Intervention versus control, Outcome 3 Graft rejection requiring medical treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/references#CD006660-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006660-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/urn:x-wiley:14651858:media:CD006660:CD006660-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_t/tCD006660-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intervention versus control, Outcome 4 Graft rejection unspecified treatment." data-id="CD006660-fig-0015" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Intervention versus control, Outcome 4 Graft rejection unspecified treatment.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/references#CD006660-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006660-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/urn:x-wiley:14651858:media:CD006660:CD006660-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_t/tCD006660-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intervention versus control, Outcome 5 Proportion of participants with infections." data-id="CD006660-fig-0016" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Intervention versus control, Outcome 5 Proportion of participants with infections. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/references#CD006660-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006660-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/urn:x-wiley:14651858:media:CD006660:CD006660-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_t/tCD006660-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intervention versus control, Outcome 6 Number of infection episodes." data-id="CD006660-fig-0017" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Intervention versus control, Outcome 6 Number of infection episodes.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/references#CD006660-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006660-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/urn:x-wiley:14651858:media:CD006660:CD006660-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_t/tCD006660-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intervention versus control, Outcome 7 Intensive therapy unit stay." data-id="CD006660-fig-0018" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Intervention versus control, Outcome 7 Intensive therapy unit stay.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/references#CD006660-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006660-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/urn:x-wiley:14651858:media:CD006660:CD006660-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_t/tCD006660-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intervention versus control, Outcome 8 Hospital stay." data-id="CD006660-fig-0019" src="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Intervention versus control, Outcome 8 Hospital stay.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/references#CD006660-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/media/CDSR/CD006660/image_n/nCD006660-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006660-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Intervention compared to control for people undergoing liver transplantation (mortality)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Mortality</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> people undergoing liver transplantation.<br/> <b>Settings:</b> tertiary.<br/> <b>Intervention:</b> intervention.<br/> <b>Comparison:</b> control. </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comparisons</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Intervention</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Selective bowel decontamination versus inactive control</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>68 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>62 per 1000</b> <br/> (21 to 185) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.91</b> <br/> (0.31 to 2.72) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>190<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Selective bowel decontamination versus prebiotics with probiotics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No mortality in either group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Selective bowel decontamination versus prebiotics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No mortality in either group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Prebiotics with probiotics versus prebiotics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No mortality in either group</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>129<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Granulocyte‐colony stimulating factor (G‐CSF) versus placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>143 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>177 per 1000</b> <br/> (89 to 353) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.24</b> <br/> (0.62 to 2.47) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>194<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> The trial(s) was (were) of high risk of bias.<br/> <sup>2</sup> There was moderate heterogeneity as noted by I<sup>2</sup> statistic.<br/> <sup>3</sup> The confidence intervals overlapped 1 and either 0.75 or 1.25 or both. The number of events in the intervention and control groups was fewer than 300. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Intervention compared to control for people undergoing liver transplantation (mortality)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD006660-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Intervention compared to control for people undergoing liver transplantation (retransplantation)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>Retransplantation</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> people undergoing liver transplantation.<br/> <b>Settings:</b> tertiary.<br/> <b>Intervention:</b> intervention.<br/> <b>Comparison:</b> control. </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comparisons</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Intervention</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Selective bowel decontamination versus inactive control</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>81 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>69 per 1000</b> <br/> (21 to 231) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.85</b> <br/> (0.26 to 2.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>132<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Selective bowel decontamination versus prebiotics with probiotics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000*</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>44 per 1000</b> <br/> (2 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.91</b> <br/> (0.12 to 68.81) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Selective bowel decontamination versus prebiotics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>16 per 1000*</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 1000</b> <br/> (2 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 3.00</b> <br/> (0.13 to 71) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Prebiotics with probiotics versus prebiotics</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>15 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>5 per 1000</b> <br/> (0 to 122) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 0.33</b> <br/> (0.01 to 7.90) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>129<br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Granulocyte‐colony stimulating factor (G‐CSF) versus placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>71 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>81 per 1000</b> <br/> (29 to 226) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.13</b> <br/> (0.40 to 3.17) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>194<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the control group risk across studies except for the two comparisons indicated which did not have any retransplantation in the control group. The overall proportion of patients who required retransplantation in the comparison was used as the control group risk in these two comparisons. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup> The trial(s) was (were) of high risk of bias.<br/> <sup>2</sup> The confidence intervals overlapped 1 and either 0.75 or 1.25 or both. The number of events in the intervention and control groups was fewer than 300. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Intervention compared to control for people undergoing liver transplantation (retransplantation)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/full#CD006660-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006660-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Intervention versus control</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Selective bowel decontamination versus inactive control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>190</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.31, 2.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Selective bowel decontamination versus prebiotics with probiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Selective bowel decontamination versus prebiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Prebiotics with probiotics versus prebiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Granulocyte‐colony stimulating factor (G‐CSF) versus placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.62, 2.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Retransplantation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Selective bowel decontamination versus inactive control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.26, 2.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Selective bowel decontamination versus prebiotics with probiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.91 [0.12, 68.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Selective bowel decontamination versus prebiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.13, 71.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Prebiotics with probiotics versus prebiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 Granulocyte‐colony stimulating factor (G‐CSF) versus placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.40, 3.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Graft rejection requiring medical treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Selective bowel decontamination versus prebiotics with probiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.94 [0.38, 9.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Selective bowel decontamination versus prebiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.32, 5.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Prebiotics with probiotics versus prebiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.12, 3.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Granulocyte‐colony stimulating factor (G‐CSF) versus placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.74 [0.94, 3.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Graft rejection unspecified treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Selective bowel decontamination versus inactive control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>111</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.85, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Prebiotics with probiotics versus prebiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.32, 2.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Proportion of participants with infections <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Selective bowel decontamination versus inactive control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>256</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.63, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Selective bowel decontamination versus prebiotics with probiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.63 [1.36, 9.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Selective bowel decontamination versus prebiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.36 [0.75, 2.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 Prebiotics with probiotics versus prebiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.03, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5 Granulocyte‐colony stimulating factor (G‐CSF) versus placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.55, 1.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Number of infection episodes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.78, 1.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Selective bowel decontamination versus inactive control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.18, 1.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Selective bowel decontamination versus prebiotics with probiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.58 [1.94, 16.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Selective bowel decontamination versus prebiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.72, 2.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 Prebiotics with probiotics versus prebiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.49, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Intensive therapy unit stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Selective bowel decontamination versus inactive control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [‐32.00, 38.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Selective bowel decontamination versus prebiotics with probiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.0 [‐23.45, 31.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Selective bowel decontamination versus prebiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.20 [‐31.12, 35.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4 Prebiotics with probiotics versus prebiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.41 [‐5.30, 2.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.5 Granulocyte‐colony stimulating factor (G‐CSF) versus placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐19.92, 19.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Selective bowel decontamination versus inactive control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [‐7.71, 8.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Selective bowel decontamination versus prebiotics with probiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.0 [‐0.82, 8.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 Selective bowel decontamination versus prebiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [‐2.39, 8.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4 Prebiotics with probiotics versus prebiotics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.49 [‐5.19, 4.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.5 Granulocyte‐colony stimulating factor (G‐CSF) versus placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>194</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐5.13, 5.13]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Intervention versus control</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006660.pub3/references#CD006660-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006660.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD006660-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006660-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD006660-note-0001">Français</a> </li> <li class="section-language"> <a class="" href="pl#CD006660-note-0002">Polski</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006660\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006660\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006660\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006660\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006660\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006660\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006660\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006660\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006660\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006660\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006660\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006660\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006660\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006660\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006660\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006660\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006660\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006660\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=8ranHhTh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006660.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006660.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006660.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006660.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006660.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740720094415"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006660.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740720094419"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006660.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918df8c6ee829377',t:'MTc0MDcyMDA5NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 